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Abbreviations  
AANAT  arylalkylamine N-acetyltransferase 
AC  adenylate cyclase 
AMPA  alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
cAMP  cyclic AMP 
BAC  bacterial artificial chromosome 
CDS  coding sequence 
D  dark period 
DMSO  dimethylsulfoxide 
DT-A  diphtheria toxin fragment A 
EC  ependymal cell layer 
EM-CCD  electron-multiplying charge-coupled device 
Epac  exchange protein directly activated by cAMP 
Epac ag exchange protein directly activated by cAMP agonist, 8-pCPT-2′-O-Me-cAMP 
in this study 
Fsk  forskolin 
Gln  glutamine 
Glu  glutamic acid 
GnRH  gonadotropin releasing hormone 
GPCR  G-protein coupled receptors 
HIOMT  hydroxyindole-O-methyltransferase 
HPT  hypothalamus–pituitary–thyroid 
IVF  in vitro fertilization 
KA  kainic acid 
L  light period 
LC-SRM/MS liquid chormatography-selected reaction monitoring/mass spectrometry 
LD  long day 
Luc  luciferase 
MDL  MDL-12,330A (MDL), a potent, irreversible inhibitor of AC 
ME  median eminence 
Mel  melatonin 
MT1  melatonin receptor 1A 
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MT2  melatonin receptor 1B 
ND  not detected 
NMDA  N-methyl-D-aspartic acid 
NK cells  natural killer cells 
PD  pars distalis 
PKA  protein kinase A 
PKA ag  protein kinase A agonist, 6-Bnz-cAMP in this study 
PKC  protein kinase C 
PLC  phospolipase C 
PMT  photomultiplier tube 
PT   pars tuberalis 
PTX  pertussis toxin 
qPCR  quantitative RT-PCR 
RI  radioisotope 
SCN  suprachiasmatic nucleus 
SD  short day 
SEM  standard error of the mean 
SRM  selected reaction monitoring 
SSRI  selective serotonin reuptake inhibitor 
T3  triiodothyroine 
T4  prohormone thyroxine 
TH  thyroid hormone 
TPA  12-O-tetradecanoyl phorbol 13-acetate (TPA), a PKC activator 
TRH  thyroid releasing hormone 
TSH  thyroid-stimulating hormone 
TSHR  thyroid-stimulating hormone receptor 
Veh  vehicle 
ZT  zeitgeber time (ZT0; ZT0 was defined as the time of light-on) 
 
Genotype representations 
WT  wild-type TSHβLuc mice 
+/L  heterozygous TSHβLuc mice 
L/L  homozygous TSHβLuc mice 
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Abstract 
Organisms have seasonal physiological changes in response to day length. Long-day stimulation induces 
thyroid-stimulating hormone beta subunit (TSHβ) in the pars tuberalis (PT), which mediates 
photoperiodic reactions such as day-length measurement and physiological adaptation. However, the 
mechanism of TSHβ induction under the long-day condition is largely unknown. To screen candidate 
upstream molecules of TSHβ, which possibly convey light information to the PT, I generated knock-in 
mice in which the Luciferase gene is targeted into the TSHβ locus so as to quantitatively monitor the 
dynamics of TSHβ expression. I cultured brain slices containing the PT region from adult and neonatal 
mice and measured the bioluminescence activities from each slice over several days. After the treatment 
of melatonin, a reported negative regulator of TSHβ, a decrease in the bioluminescence activities were 
observed. These observations indicate that the slice possess in vivo-like responsiveness of the TSHβ 
expression to melatonin. Thus, I concluded that my experimental system could monitor TSHβ expression 
dynamics in response to external stimuli. I performed preliminary screening for candidate upstream 
molecules of TSHβ, and I tested drugs targeting the intracellular signaling pathways, hormones, and so on, 
by using this monitoring system. Glutamic acid increased the bioluminescence activities acutely and 
transiently, consistent with previous study (Aizawa et al. 2012). These findings suggest that glutamic acid 
is a strong candidate of TSHβ upstream molecules and this monitoring system can response to candidate 
TSHβ-inducible signals. Therefore, TSHβ real-time monitoring system is a powerful tool to screen 
upstream molecules of TSHβ. 
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General introduction	 
1. General view of photoperiodism 
Photoperiodism 
The earth’s rotation creates the daily cycle of light and darkness, while the earth’s revolution with its spin 
axis tilted at 23.4° creates the variation in seasons. The environment varies considerably throughout the 
seasons, such as low food availability during winter. Organisms living in seasonal environments predict 
seasonal changes and adapt their physiology and behavior to promote survival. Plants flower at a specific 
season. Animals adapt timing of reproductive activity to produce offspring at an optimal time of year 
when food supply should be plentiful, while animals migrate or hibernate when food availability is low. 
Thus, precise timing of physiology and behavior is critical for individual reproductive success and 
subsequent fitness. Day-length (photoperiod) is a highly reliable cue as a calendar. Seasonal changes in 
day-length are constant throughout each year. Organisms can use this signal to anticipate and prepare for 
seasonal changes. The response of organisms to changes in day-length is known as photoperiodism, and 
seasonal reproduction is an example of photoperiodic responses. 
 
Involvement of the circadian clock in photoperiodism 
The circadian clock is an autonomous system that controls many physiological and behavioral systems to 
adapt 24-h environmental light/dark cycle. This has approximately 24-h rhythmicity in constant condition 
and it entrains to an exact 24-h rhythmicity by daily light. The circadian clock is composed of genes 
(circadian clock genes) that interact in oscillatory transcriptional networks within cells (Albrecht 2002; 
Ueda et al. 2005) and regulate the expression of many other genes critical for physiology and metabolism. 
The suprachiasmatic nucleus (SCN) in the hypothalamus is the master organ of the circadian clock and 
the SCN synchronizes all the circadian clocks in the body in mammals (Welsh et al. 2010). 
Bünning proposed the idea that the measurement of day-length might be based on circadian rhythms in 
plants (Bünning 1936). Since then, studies of plants (Nanda & Hamner 1958) and mammals (Hamner 
1963; Elliott et al. 1972; Grocock & Clarke 1974; Stetson et al. 1976; Wada 1979) have established a role 
for circadian rhythms in day-length measurement. When house finches are exposed to a range of light 
cycles each containing a 6-h of light coupled to various length of darkness (6, 18, 30, 42, 54, and 66 hours 
of darkness) to give overall cycles ranging from about 12 to 72 hours, the 6-h light period coupled with 
dark periods in cycle lengths of 24, 48, and 72 hours does not stimulate testicular growth (a long-day 
photoperiodic response), but induce the response in cycles of 12, 36, and 60 hours (Hamner 1963). Thus, 
timing of a 6-h of light, which can trigger testicular growth (called as photoinducible phase), appearing at 
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24-h intervals was suggested to be important (Fig. G1). Similar observations were also reported 
gonadotropin secretion in the white-crowned sparrow (Follett et al. 1974) and testis function in Syrian 
hamsters (Elliott et al. 1972). In addition, the lesions of the SCN disrupt the testicular responses to 
day-length in Syrian hamsters (Rusak & Morin 1976; Stetson & Watson-Whitmyre 1976). All of these 
observations clearly suggest the involvement of the circadian clock in day-length measurement. 
 
Melatonin represents light information in mammals 
Mammals perceive light with the eyes and the light signals are transmitted to the pineal via a 
multisynaptic pathway including the retinohypothalamic tract, the SCN, and the sympathetic nervous 
system. Under the control of this pathway, including the exogenous light input and the circadian clock, 
the pineal organ synthesizes and secretes melatonin during the dark phase (Reiter 1980; Arendt 1998) 
(Fig. G2). Therefore, when the night length is long, the duration of melatonin secretion is long (winter) 
and when the night length is short, the duration of melatonin secretion is short (summer). Thus, melatonin 
is the endocrine representation of the period of darkness, inversely reflecting day-length. Furthermore, 
pinealectomy (disruption of melatonin secretion) abolishes seasonal responses in hamsters (Hoffman & 
Reiter 1965; Hoffmann 1979). Melatonin injections given at dusk or before dawn are sufficient to induce 
a short day-length (short-day) typical gonadal response in Syrian hamsters kept under long day-length 
(long-day) conditions (Turek et al. 1975; Tamarkin et al. 1976). These observations support that 
melatonin transmits external light information as darkness information and plays an important role in 
photoperiodism. Although eyes are believed to be the only photoreceptor organs in mammals, and 
removal of the eyes abolishes the photoperiodic response (Reiter 1980), removal of the eyes does not 
affect photoperiodic response in birds (Benoit 1935a, 1935b; Foster & Soni 1998). Instead, birds perceive 
light via deep brain photoreceptors expressed in the brain, and Opsin-5 and VA-opsin are identified as 
deep brain photoreceptors (Halford et al. 2009; Nakane et al. 2010; Yamashita et al. 2010). Recently it is 
reported that Opsin-5 is involved in TSHβ induction (Nakane et al. 2014). 
In summary, both internal time information and environmental light information are necessary for 
day-length measurement. However, the integration process of this information remains largely unknown. 
 
The pars tuberalis is an important tissue for day-length measurement 
In vitro autoradiography and in situ hybridization studies have identified areas of the brain that express 
melatonin receptors and could potentially receive seasonal variations in daily nocturnal melatonin profiles. 
The pars tuberalis (PT) is a common site expressing melatonin receptors among mammals (sheep, deers, 
goats, rabbits, rats, Syrian hamsters, Djungarian hamsters, mice, and ferrets), including seasonal animals 
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(Morgan et al. 1994) (Fig. G2). The PT is a tissue composed of highly vascularized multicellular tubes 
surrounding the pituitary stalk (Stoeckel & Porte 1984) (Fig. G3). The PT is an interface between the 
hypothalamus, which regulates reproduction, and the pars distalis (PD), which is part of the pituitary and 
contains the bulk of the hormone-secreting cells. Two melatonin receptor subtypes, MT1 and MT2, are 
identified in mammals. Both MT1 and MT2 belong to the large G protein-coupled, seven-transmembrane 
protein family (Dubocovich et al. 2003). MT1 appears to be the highly dominant subtype in the PT 
because targeted disruption of its gene in mice leads to undetectable levels of an 2-[125I]iodomelatonin 
binding (Liu et al. 1997), while MT2 is believed to be naturally nonfunctional in highly photoperiodic 
species such as Siberian hamster (Weaver et al. 1996). Therefore, it is believed that the PT is responsible 
for day-length measurement thorough MT1. 
The PT consists of several types of cells including PT-specific secretory cells, follicular cells, and 
PD-like endocrine cells (Stoeckel et al. 1979; Rudolf et al. 1993). PT-specific secretory cells are a major 
content of the PT and they show immunoreactivity of thyroid-stimulating hormone (TSH), thus called as 
thyrotrophs (Wittkowski et al. 1999). Generally, the PD is a major organ that secretes TSH, and 
TSH-secreting cells in the PD are also called as thyrotrophs. TSH is a heterodimer of thyroid-stimulating 
hormone beta subunit (TSHβ), which is a unique beta subunit of TSH, and common glycoprotein alpha 
subunit (Cga), which is a common alpha subunit of TSH, follicle stimulating hormone and luteinizing 
hormone. However, regulatory mechanisms of TSH in the PT thyrotrophs are different from that in the 
PD thyrotrophs. TSH in the PD thyrotrophs is controlled by the negative feedback loop of the 
hypothalamus–pituitary–thyroid (HPT) axis, and they show responsiveness to thyroid releasing hormone 
(TRH) and thyroid hormone (TH). In contrast, the TSHβ expression in ovine PT did not change by TRH 
and TH treatment, because of the lack of TRH and TH receptors or transcription factor Pit-1, which 
induces TSHβ in the PD (Bockmann et al. 1997). These observations suggest that thyrotrophs in the PT 
are not controlled by the negative feedback loop of the HPT axis. On the other hand, TSH 
immunoreactivity in the PT of the Djungarian hamster changed by day-length (Wittkowski et al. 1988). 
Taken together, the tissue apparently responds to light conditions, possibly through melatonin signal, 
rather than the hormonal feedback loop. 
It is also reported that circadian clock genes are expressed and oscillating in the PT (Ansari et al. 2009), 
and the expressions are apparently affected by melatonin signal (Fig. G3). It was shown that MT1 and 
RORβ, which is one of the circadian clock genes, are co-expressed in the rat PT (Klosen et al. 2002). 
Pinealectomy abolished expression of period 1 (Per1) (Messager et al. 2001) in the PT, and rhythmic 
expressions of circadian clock genes such as Per1, Cry1, Clock, and Bmal1 were also abolished in the PT 
of MT1 knockout mice (von Gall et al. 2002; Jilg et al. 2005). These reports indicate that the circadian 
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clock in the PT is affected by melatonin. However, the mechanism by which light information such as 
melatonin is decoded within the PT is still unknown. 
 
2. General view of molecular mechanism for day-length detection 
TSH represents long-day detection in the PT 
It was known for long time that administration of TH mimics the physiological effects of long-day 
condition (Follett & Nicholls 1985; Goldsmith & Nicholls 1992) such as testicular growth of Japanese 
quail, (Coturnix japonica), which is the obvious seasonal change of the animal. The quail is a well-used 
model for studying photoperiodism, because the animal shows such rapid reproductive response to 
changing day-length, and functional gene expression analysis in the quail revealed the role of TSH and 
TH on the reproductive function (Yoshimura et al. 2003; Nakao et al. 2008). As summarized in Fig. G4, 
it was found that TSHβ gene was rapidly induced in the PT within several hours after exposure of the 
animal to the long-day condition. In contrast, Cga was constantly expressed in the PT. Because TSH is 
believed to act on TSH receptor (TSHR) as a heterodimer peptide hormone, functional dynamics of TSH 
heterodimer are dependent on the expression levels of TSHβ rather than Cga. The TSH heterodimer from 
the PT binds to TSHR expressed in the ependymal cell layer (EC) of the third ventricle and regulates the 
expression of type 2 iodothyronine deiodinase (Dio2) and type 3 deiosinase (Dio3). Dio2, a thyroid 
hormone activating enzyme, then converts the prohormone thyroxine (T4) to bioactive triiodothyroine 
(T3). Interestingly, blood concentration of TH did not alter between short-day and long-day conditions. 
Thus, induction of Dio2 by TSH might cause local increase in T3 concentration under the long-day 
condition and photoperiodic responses. Furthermore, intracerebroventricular infusion of T3 or TSH 
mimics photoperiodically induced testicular growth (Yoshimura et al. 2003; Nakao et al. 2008). These 
findings suggested a new role of TSH and TH on reproduction in quail’s photoperiodism and TSH is 
considered as a photoperiodic marker of long-day detection (Fig. G4). 
 
TSH responsiveness in mammalian photoperiodism 
This TSH-Dio2 molecular mechanism has also been conserved among mammals, including the mouse 
(Ono et al. 2008), Syrian hamster (Yasuo et al. 2010), European hamster (Hanon et al. 2010), sheep 
(Hanon et al. 2008) and rat (Ross et al. 2011). In general, laboratory mice are considered to be 
non-seasonal animals because they do not show photoperiodic phenotypes such as seasonal reproduction. 
Furthermore, many strains of mice have genetic mutations of two rate-limiting enzymes for melatonin 
synthesis from serotonin (arylalkylamine N-acetyltransferase (AANAT) and 
hydroxyindole-O-methyltransferase (HIOMT)) and thus these strains lack melatonin productivity 
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(Ebihara et al. 1986; Goto et al. 1989). However, limited melatonin-proficient mice strains such as 
CBA/N display similar photoperiodic gene responses of TSHβ and Dio2 by long-day stimulation as seen 
in the quail, while such responses were not observed in the melatonin-deficient C57BL/6 strain (Ono et al. 
2008; Masumoto et al. 2010). These observations indicate that the photoperiodic gene response is also 
conserved in mice, suggesting possible usefulness of the animal for photoperiodism study. 
 
Melatonin regulates TSHβ expression in the PT 
MT1 and TSHβ are co-expressed in the same cell of the rat PT (Wittkowski et al. 1988; Klosen et al. 
2002). Melatonin injection suppressed TSHβ in the PT in mice, sheep and hamsters (Hanon et al. 2008; 
Ono et al. 2008; Yasuo et al. 2010). Furthermore, photoperiodic regulation of Dio2 and Dio3 expression 
is abolished in MT1 knockout mice (Yasuo et al. 2009). These reports suggest that melatonin-MT1 
pathway potentially regulates TSHβ and further downstream targets that are important for day-length 
measurement. 
 
3. Upstream cascade of TSHβ 
TSHβ induction mechanism 
In the comprehensive gene expression analysis in Japanese quail, transcription cofactor eyes absent 3 
(Eya3) was also identified which shows rapid induction by long-day stimulation as seen in TSHβ (Nakao 
et al. 2008). In melatonin-proficient mice, we reported that Eya3 induction preceded TSHβ induction, and 
Eya3 transactivated TSHβ with DNA binding transcription factor sine oculis-related homeobox 1 (Six1) 
(Masumoto et al. 2010). Similar Eya3-TSHβ mechanism was also found in sheep (Dardente et al. 2010). 
Endogenous time determined by the circadian clock is as important as light signals for TSHβ induction. 
We revealed the importance of timing of long-day stimulation for rapid TSHβ induction. When mice were 
stimulated to long-day condition from short-day by advancing lights-on (late-night) or delaying lights-off 
(early-night) for 8 hours, late-night light stimulation immediately induced TSHβ expression in the PT 
within several hours while early-night light stimulation did not increased TSHβ within a day. Early-night 
light stimulation increased TSHβ gradually over the 5 days (Fig. G5). It was indicated that late-night light 
stimulation is necessary for immediate TSHβ induction in mammalian photoperiodism. Late-night time 
may be photoinducible phase in mammals. 
We also found that expression patterns of circadian clock genes were not affected by late-light light 
stimulation while those expression patterns were perturbed by early-night light stimulation and the PT 
circadian time was gradually shifted over 5 days, as seen in jet-lag. It is implied that the PT circadian 
clock was entrained to the lights-off timing. Melatonin may be included this entrainment because the start 
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of melatonin secretion reflects lights-off timing and melatonin affects expression patterns of the circadian 
clock genes. Thus, expression patterns of clock genes may correspond to induction patterns of TSHβ after 
long-day stimulation. 
Furthermore, it was found that several circadian clock-controlled genes such as thyrotroph embryonic 
factor (Tef) and/or hepatic leukemia factor (Hlf) regulated TSHβ expression synergistically with Eya3 and 
Six1 by in vitro TSHβ promoter assay (Dardente et al. 2010; Masumoto et al. 2010) (Fig. G6). Bmal1 and 
Clock also upregulated TSHβ promoter activity (Unfried et al. 2010). These reports indicate that circadian 
clock genes control TSHβ expression. Thus, endogenous time determined by circadian clock genes is 
important for optimal TSHβ expression in photoperiodic reaction. 
 
Intracellular melatonin signal transduction pathways in the PT 
Molecules working in the downstream of MT1, a receptor subtype that is believed to mainly mediate 
photoperiodic responses conveyed by melatonin in the PT, are well studied by using ovine PT 
dissociation culture system. MT1 antagonize the induction of cAMP levels by adenylate cyclase (AC) 
activator forskolin (Morgan et al. 1989a; Morgan et al. 1989b). The effects were canceled by the 
G-protein inhibitor, pertussis-toxin (PTX), suggesting that MT1 couples to a Gi protein (Morgan et al. 
1990). The Gi pathway of MT1 is believed to negatively regulate intracellular cAMP levels. Intriguingly, 
chronic melatonin treatment of PT cells sensitizes AC such that the induction of cAMP by forskolin can 
be greatly enhanced upon removal of melatonin (Barrett et al. 2000; Barrett et al. 2003). These results 
may suggest that sensitization of AC by the chronic melatonin treatment have some role for fine-tuning of 
day-length measurement. However, it is unknown whether the sensitizing effect is observed in vivo. The 
role of the sensitization and involving molecular mechanisms in the context of melatonin’s action are not 
entirely clear. 
Whereas melatonin signaling through MT1 leads to decrease in the intracellular cAMP levels, signals that 
increase cAMP levels are unknown. Although removal of melatonin increased intercellular cAMP 
concentration slightly in ovine PT cell culture (Hazlerigg et al. 1993), it may be insufficient to initiate an 
action in vivo. These observations may imply that melatonin acts indirectly to inhibit the effects of an 
unknown stimulatory factor, which increases cAMP levels in the PT. 
 
How can connect the light, melatonin, and TSHβ? 
Detailed pathway from light detection on the eyes to TSHβ induction in the PT is unclear, whereas it is 
obvious that light regulates melatonin-MT1-TSHβ pathway. Cyclic AMP signal transduction might be 
one of important mechanisms of inducting TSHβ in the PT. However, there is no report showing light 
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dependency of the cAMP signal in the PT and the relationship between the cAMP signal and TSHβ (Fig. 
G7).  
Eya3 is also regulated by melatonin, because melatonin injection suppressed Eya3 in the ovine PT 
(Dardente et al. 2010). Suppression of Eya3 and TSHβ expression in the PT by melatonin injection 
implies that an unknown stimulatory factor may reversely induce Eya3 and TSHβ thorough elevation of 
cAMP levels (Ono et al. 2008; Dardente et al. 2010; Masumoto et al. 2010; Yasuo et al. 2010). Light 
information for detecting long-day stimulation on the eyes might be transferred immediately to the PT 
and increase cAMP levels, because long-day stimulation induced Eya3 in the PT within 4 hours 
(Masumoto et al. 2010). Circadian clock genes may also associate cAMP accumulation in the PT and/or 
Eya3 and TSHβ induction. However, signal transduction, which increases cAMP levels in the PT, remains 
unclear. 
It is also unknown whether other signal transduction pathways such as calcium signals are involved in the 
PT. Thus, wide range of examinations of several molecular mechanisms is important. So far, it has been 
difficult to study these detailed molecular mechanisms because genetics were not available in model 
animals in photoperiodism study (Japanese quail, sheep, and so on). Recent studies revealing that 
melatonin-proficient mice possess photoperiodic gene response opened the door to apply techniques in 
mammalian genetics such as gene targeting and transgenic strategy to the research field. Thus, using mice 
was expected to promote studies about the molecular mechanisms in the PT and light information 
transferring pathway from the eyes to the PT. 
 
4. Aim of this study: Identification of light information transferring molecules 
Induction of TSHβ in the PT is a marker for long-day detection as a result of integration of time 
information and light information. Light information-transferring molecule is unknown, whereas 
melatonin transfers darkness information to the PT. Furthermore, the detailed molecular mechanisms of 
induction of Eya3 and TSHβ in the PT are not clear as well. In this thesis, I focused on how TSHβ 
expression in the PT is regulated by long-day stimulation because TSHβ shows significant induction by 
long-day stimulation within several hours. Moreover, the photoperiodic role of TSHβ is revealed, and the 
PT is an interface of seasonal reproduction. Conventional methods require an immense amount of care 
and time. For example, intraventricular administration of drugs or proteins, gene transfection or RNAi 
knockdown in vivo are needed for perturbing putative upstream molecule, and in situ hybridization or 
immunostaining are required for evaluating the effects of perturbation. These methods are not convenient 
for screening putative TSHβ upstream molecules because upstream cascade of TSHβ is largely unknown. 
Thus, I established screening systems of candidate upstream molecules of TSHβ under conditions similar 
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to in vivo conditions. I performed preliminary screening of candidate upstream molecules of TSHβ such 
as drugs targeting the cAMP signal, hormones, and so on by using this screening system, and I found that 
glutamic acid show TSHβ-inducible activity. These results were consistent with previous study that show 
glutamic acid can induce TSHβ in rat PT, suggesting that this screening system is functional (Aizawa et al. 
2012). Unexpectedly, activators of cAMP-related molecules did not increase bioluminescence activities 
immediately after the treatment as seen in TSHβ induction in vivo (Masumoto et al. 2010). From these 
results, I propose my screening system “TSHβ real-time monitoring system” is a powerful tool to reveal 
photoperiodic molecular mechanisms. 
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Figure G1. The circadian clock is involved in day-length measurement. Birds are exposed to a range of 
light cycles each containing a 6-h of light (L) coupled to various length of darkness [6, 18, 30, 42, 54, and 
66 hours of darkness (D)]. Timing of a 6-h of light, which can trigger testicular growth, appeared at 24-h 
intervals (Hamner 1963). Light pulses given at a specific time of day called the “photoinducible phase” 
induce testicular growth in birds. 
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Figure G2. The day-length input pathway in mammals. Light is perceived by photoreceptors 
(melanopsin-containing ganglion cells) in the retina, which project directly to the suprachiasmatic nucleus 
(SCN). The SCN generates circadian rhythms and the SCN controls pineal melatonin production. Pineal 
melatonin is released in the bloodstream at night and reflects the night length of day-length. Melatonin 
binds to the melatonin receptors in the highly vascularized pars tuberalis (PT), where it also expresses 
circadian clock genes. 
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Figure G3. Schematic drawing of a sagittal section (left) and a coronal section (right) of the hypothalamus 
and the pituitary with special reference to topographic relations of the pars tuberalis (gray) of the anterior 
pituitary. 
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Figure G4. Photoperiodic signal transduction cascade in birds. Light information detected by deep brain 
photoreceptor is transmitted to the pars tuberalis (PT), inducing thyroid-stimulating hormone (TSH). TSH 
in the PT acts on the ependymal cells to induce thyroid hormone-activating enzyme, type 2 deiodinase 
(Dio2). Triiodothyronine (T3) converted from thyroxine (T4) by Dio2 regulates gonadotropin releasing 
hormone (GnRH) secretion and hence gonadotropin secretion from the anterior pituitary gland. 
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Figure G5. Light stimulation at a specific time can induce TSHβ rapidly. 8-h advanced lights-on 
(late-night light) induced TSHβ within several hours. The PT circadian clock was not affected by 
late-light stimulation. In contrast, 8-h delayed lights-off (early-night light) did not induce TSHβ within the 
first day. The PT circadian clock was perturbed by early-light stimulation and it was entrained gradually. 
Modified from Masumoto, K. H. et al. (2010) Curr Biol. 
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Figure G6. Acute induction of Eya3 by late-night light stimulation triggers TSHβ expression in 
photoperiodism. Eya3 and its partner Six1 synergistically activate TSHβ expression and that this 
activation is further enhanced by Tef and/or Hlf. 
 21 
 
	  
Figure G7. A model for interactions between melatonin, cAMP, TSHβ, and other transcription factors in 
the PT cells. In short-day condition, melatonin suppresses intercellular cAMP concentration thorough 
MT1. This may decrease Eya3 and TSHβ expression. In contrast, sutimulator X, may elevates 
intercellular cAMP concentration and may induce Eya3 and TSHβ under long-day condition. Eya3 
transactivated TSHβ with DNA binding transcription factor Six1. Several circadian clock-controlled genes 
such as Tef and/or Hlf regulated TSHβ expression synergistically with Eya3 and Six1. Circadian clock 
genes Bmal1 and Clock also upregulated TSHβ promoter activity. 
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Establishment of TSHβ real-time monitoring system in mammalian photoperiodism 
 
	 
Introduction 
Many organisms adapt their physiological functions and behaviors to seasonal environmental changes by 
measuring day length, a biological process known as photoperiodism (Dawson et al. 2001; Ebling & 
Barrett 2008; Revel et al. 2009). Integration of external light information and endogenous time mediated 
by circadian clock genes (clockwork genes) is important for the photoperiodic responses (Hamner 1963; 
Pittendrigh & Minis 1964). 
The pars tuberalis (PT) of the pituitary gland may be responsible for the photoperiodic responses because 
of the high expression levels of the clockwork genes and melatonin receptor 1a (MT1) in the PT (Morgan 
& Williams 1996; Lincoln et al. 2003; Ikegami & Yoshimura 2012). In mammals, it is suggested that 
nocturnal melatonin conveys darkness information to the PT, but the molecules conveying light 
information remain unknown (Hoffman & Reiter 1965; Morgan & Williams 1996). In a recent study, 
thyroid-stimulating hormone beta subunit (TSHβ) gene was found to be rapidly induced by long-day 
stimulation in the PT and the product of TSHβ, thyroid-stimulating hormone (TSH), has a functional role 
in seasonal testicular growth in birds (Yoshimura et al. 2003; Nakao et al. 2008). This TSHβ induction is 
conserved even in mammals including melatonin-proficient mice (Hanon et al. 2008; Ono et al. 2008; 
Dardente et al. 2010; Dupre et al. 2010; Masumoto et al. 2010; Yasuo et al. 2010). Therefore, TSHβ is a 
key factor for day-length detection and controls seasonal physiological changes. 
Delivery of light information from the retina to the PT is an important pathway for inducing TSHβ 
expression and regulating photoperiodic responses. Indeed, removal of the eyes, the suprachiasmatic 
nucleus or the pineal gland disrupts testicular responses in hamsters (Hoffman & Reiter 1965; Rusak & 
Morin 1976; Stetson & Watson-Whitmyre 1976). In the mouse PT, long-day stimulation induces a 
transcription cofactor eyes absent 3 (Eya3) (Masumoto et al. 2010). This molecule regulates TSHβ 
expression with DNA-binding transcription factor sine oculis-related homeobox 1 (Six1) and several 
clockwork genes such as thyrotroph embryonic factor (Tef) and/or hepatic leukemia factor (Hlf) 
(Dardente et al. 2010; Masumoto et al. 2010). These molecular mechanisms have also been found in 
sheep (Dardente et al. 2010; Dupre et al. 2010). On the other hand, darkness information is mediated by 
melatonin that suppresses Eya3 and TSHβ expression in sheep and mice, respectively (Ono et al. 2008; 
Unfried et al. 2009; Dardente et al. 2010; Yasuo et al. 2010). Thus, the regulation of Eya3 by external 
light conditions is critical to control TSHβ expression for photoperiodism. However, the intracellular and 
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extracellular signals that transfer the external light information to the PT to regulate Eya3 and TSHβ 
expression remain unknown. 
In this study, I focused on how TSHβ expression in the PT is regulated by long-day stimuli. To 
accomplish this, I established a real-time monitoring system for measuring TSHβ expression dynamics for 
the purpose of screening candidate light information-transferring signals in the PT. I generated a genetic 
mouse model in which TSHβ expression dynamics in the PT can be visualized by bioluminescence. 
Treatment of cultured PT slices with melatonin decreased bioluminescence activities, and these results 
showed that PT slices can response to melatonin in my culture condition. Furthermore, I performed 
preliminary screening for candidate upstream molecules of TSHβ such as drugs targeting the cAMP 
signal by using this TSHβ real-time monitoring system, and I found that glutamic acid increased 
bioluminescence activities acutely, consistent with previous study (Aizawa et al. 2012). In contrast, 
activators of cAMP-related molecules did not increase bioluminescence activities immediately after the 
treatment as seen in TSHβ induction in vivo. These observations suggest that this screening system could 
response to external signals. Thus, my mouse model could be used to search for molecules that relay 
external light signals in the PT. 
 29 
 
Results 
1. Establishment of TSHβ real-time monitoring system in mammalian photoperiodism 
Generation of TSHβLuc mice 
To monitor TSHβ expression in the PT, I applied a knock-in approach in which 5′ exon of TSHβ-coding 
sequence was knocked out and replaced with a firefly Luciferase (Luc) gene (Fig. 1A). In this scheme, the 
luc activity represents direct transcription from the endogenous TSHβ promoter. Southern blot analysis 
confirmed that the desired mutation was successfully introduced (Fig. 1B, left), and genotypes of 
offspring were routinely analyzed by PCR (Fig. 1B, right). Animals were backcrossed and maintained on 
a CBA/N background because unlike the more common C57BL/6 strain, CBA/N mice maintain 
melatonin proficiency (Ebihara et al. 1986; Nakahara et al. 2003). 
To verify the loss of TSHβ transcript, I performed quantitative RT-PCR (qPCR) to measure the 
expression levels of TSHβ and its related genes in the pituitary composed of the anterior and posterior 
lobes, where the highest TSHβ expression level in the brain was observed (Kasukawa et al. 2011). By 
using primers aligned within exon 4, which was deleted by the targeting (Fig. 1A), TSHβ mRNA was 
undetectable in homozygous TSHβLuc mice. On the other hand, only 12% decrease in TSHβ expression 
levels was observed in heterozygous TSHβLuc mice compared with wild-type mice (Fig. 1C). The 
expression levels of common glycoprotein α-subunit (Cga), the alpha subunit of TSH, were not different 
between wild-type and heterozygous TSHβLuc mice, but there was a 4-fold increase in homozygous 
TSHβLuc mice (Fig. 1C), suggesting antirepression of negative feedback loop due to the disruption of the 
TSH heterodimer. Luc expression levels were observed in heterozygous TSHβLuc mice, significantly 
increased in homozygous TSHβLuc mice and undetectable in wild-type mice, also suggesting the 
disruption of the TSH heterodimer (Fig. 1C). One hundred and thirty-seven offspring from heterozygous 
matings were examined. 30 animals were wild-type (21%), 85 heterozygous (53%) and 35 animals 
homozygous TSHβLuc mice (26%). These results are consistent with single-gene Mendelian inheritance, 
indicating that the TSHβ null mutation did not lead to fetal loss and TSHβ was not necessary for 
embryonic growth or viability. However, male and female homozygous TSHβLuc mice were sterile. 
Weekly body weight results showed that homozygous TSHβLuc mice display a low rate of growth, 
whereas heterozygous TSHβLuc mice were indistinguishable from wild-type mice (Fig. 1D). These results 
indicate that slightly reduced TSHβ expression and Luc expression do not affect the physiology in 
heterozygous TSHβLuc mice. In addition, growth retardation in homozygous TSHβLuc mice was recovered 
by supplementation with 100 ppm thyroid powder, consistent with the observation in TSH receptor 
(TSHR) knockout mice (Marians et al. 2002) (Fig. 1D). From these observations, I concluded that 
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phenotypes of heterozygous TSHβLuc mice are comparable with those of wild-type mice. 
 
Relationship between TSHβ and Luc expression in TSHβLuc mice 
Next, I checked whether the knock-in Luc mice respond to changes in day length similar to endogenous 
photoperiodic genes in the PT. TSHβ, Luc and Cga expressions in the PT of wild-type and heterozygous 
TSHβLuc mice under different day-length conditions were analyzed by radioisotope (RI) in situ 
hybridization. After 3 weeks of exposure to short-day [light/dark = 8:16 hour (L8 : D16), zeitgeber time 0 
(ZT0; ZT0 was defined as the time of lights-on) = lights-on, ZT8 = lights-off] or long-day (L16 : D8, ZT0 
= lights-on, ZT16 = lights-off) conditions, brain samples from each light condition were collected 4 h 
before lights-off that corresponds to the same circadian phase under both conditions (Masumoto et al. 
2010) (Fig. 2A). TSHβ, Luc and Cga were detected only in the PT under both conditions, and the TSHβ 
expression increased 2.5-fold under long-day conditions in wild-type and heterozygous TSHβLuc mice. 
Although Luc expression was almost undetectable in heterozygous TSHβLuc mice under short-day 
conditions and not detected in wild-type mice, its expression was clearly detected in heterozygous 
TSHβLuc mice under long-day conditions (Fig. 2B). I also observed that Cga expression pattern was 
comparable in wild-type and heterozygous TSHβLuc mice. These results indicate that the Luc expression 
represents the physiological photoperiodic responses of TSHβ in the PT and does not affect the 
expressions of endogenous TSHβ and Cga. 
 
PT-specific signals of the TSHβ-Luc reporter 
To detect bioluminescence derived from the TSHβ promoter in the PT region, I prepared brain slices 
including regions from TSHβLuc mice. First, I monitored the spatial pattern of the bioluminescence 
activity in the slice with a macrozoom microscope and a CCD camera. As expected, bioluminescence 
activity was observed only in the putative PT region surrounding the median eminence of the slices from 
5- to 6-week-old (adult) heterozygous TSHβLuc mice kept under long-day conditions for 2–3 weeks (Fig. 
2C). These spatial bioluminescence patterns are compatible to signals of Luc mRNA (Fig. 2B,C). By 
contrast, no bioluminescence was observed in the slices from wild-type mice (Fig. 2C). Therefore, 
bioluminescence activity measured in the slice can be attributed to luc activity in the PT. In addition, 
similar bioluminescence pattern in the slices from adult mice was observed in the slices from postnatal 6- 
to 8-day-old (neonate) heterozygous TSHβLuc mice kept under L12 : D12 (ZT0 = lights-on, ZT12 = 
lights-off) conditions (Fig. 2C). These observations are consistent with the TSHβ expression in vivo 
(Schulze-Bonhage & Wittkowski 1990; Japon et al. 1994) and thus imply the possibility of slice usage 
from both adult and neonatal PT. 
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Real-time bioluminescence monitoring of the TSHβ-Luc reporter 
Next, I developed a real-time monitoring system for TSHβ-Luc bioluminescence by a photomultiplier 
tube (PMT). Because Luc appears to be specifically expressed in the PT of the slice (Fig. 2C), photon 
counts by PMT measurements represent a mean bioluminescence of the tissue. First, the bioluminescence 
signals of slices from adult heterozygous TSHβLuc mice kept under short- or long-day conditions for 2–3 
weeks (adult short- or long-day slices) were measured (Fig. 3A,B). Significantly higher bioluminescence 
signals were detected from adult long-day slices than from adult short-day slices and wild-type slices. I 
further checked whether the slices have in vivo-like responsiveness to photoperiodic signals. I treated 
adult long-day slices with 10 nM of melatonin from subjective ZT16 (ZT16 is the start of the culture and 
subjective night) (Fig. 3C). In agreement with previous in vivo studies (Ono et al. 2008; Unfried et al. 
2009; Yasuo et al. 2010), a decrease in luc activity was observed by melatonin treatment. These results 
suggest that the experimental system keeps TSHβ response to melatonin even in my culture condition. 
One important application of this real-time monitoring system is to screen molecules that convey light 
signals under long-day conditions and induce the TSHβ expression. Thus, I examined the possibility of 
using of neonatal tissues instead of adult tissues because of some advantages: (i) higher viability of 
tissues, (ii) ease of slice preparation and (iii) significant signal levels even in L12 : D12 conditioned 
animals rather than long-day conditioned animals (Fig. 2C). To check whether neonatal tissues can be 
used for the monitoring assay, luc activity in the PT slices of neonatal heterozygous TSHβLuc mice kept 
under L12 : D12 conditions (neonatal slices) was measured (Fig. 3A). The robust bioluminescence 
activities of the neonatal slices were observed for over 2 days and gradually reached baseline levels after 
additional 2 or 3 days (Fig. 3D), with dynamics similar to those in adult long-day slices. Continuous 
luminescence in the PT for 2–4 days by imaging neonatal slices again confirmed that whole-tissue 
bioluminescence approximates activity in the PT (Fig. 4). Luminescence was also observed in individual 
PT cells over 4 days, but with noisy fluctuations (Fig. 4B). Furthermore, the neonatal slices were treated 
with various concentrations of melatonin, and dose-dependent repression was observed (Fig. 3E). These 
patterns of bioluminescence with or without melatonin were similar to the results in the adult long-day 
slices and in vivo. 
To independently confirm that the observed dynamics of bioluminescence is correlated with endogenous 
TSHβ expressions in neonatal PT slices, the expression levels of TSHβ, Eya3 and Cga, which are known 
to be decreased by melatonin (Ono et al. 2008; Unfried et al. 2009; Dardente et al. 2010; Yasuo et al. 
2010), were measured by qPCR. Cultured PT tissues with vehicle or 10 nM of melatonin treatment for 48 
h after the start of the culture were collected and subjected to qPCR analysis. The values of sine 
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oculis–related homeobox 5 (Six5) and potassium voltagegated channel, subfamily Q, member 5 (Kcnq5) 
were used for measuring the relative PT amounts of the samples and normalizing TSHβ values and related 
genes, because Six5 and Kcnq5 expression is specific to the PT and does not respond to melatonin (Dupre 
et al. 2008; Masumoto et al. 2010). Consistent with in vivo observations (Ono et al. 2008; Unfried et al. 
2009; Dardente et al. 2010; Yasuo et al. 2010) and bioluminescence results, the expression levels of 
endogenous TSHβ, Eya3 and Cga were significantly decreased under melatonin treatment, excluding the 
possibility that the decrease in the bioluminescence by melatonin might be an artifact (Fig. 3E,F). In 
addition, there was a strong positive correlation between TSHβ mRNA levels by qPCR analysis and 
bioluminescence counts of the PT slices by PMT measurements (r2 = 0.71; Fig. 3F, right). Furthermore, 
the culture medium of neonatal PT slices in Fig. 3F was collected, and secreted TSHβ amounts were 
measured by mass spectrometry. In the melatonin-treated culture medium, secreted TSHβ amounts were 
50% lower than vehicle-treated samples (Fig. 3G). There was a strong correlation between secreted TSHβ 
amounts and the bioluminescence counts (r2 = 0.81; Fig. 3G, middle) as well as the TSHβ mRNA levels 
(r2 = 0.66; Fig. 3G, right). These results indicate that the responsiveness of the luc activity to an external 
signal reflects TSHβ mRNA expression and secreted TSHβ protein. 
Recently, it was reported that glutamine and glutamic acid induce the TSHβ expression in the rat PT 
(Aizawa et al. 2012). To check whether the mouse PT also responds to glutamine and glutamic acid, the 
slices were treated with 1 mM of glutamine or 1 mM of glutamic acid after 2 h of glutamine and glutamic 
acid starvation. Although no response was observed by glutamine treatment, a transient increase in luc 
activity was observed by glutamic acid treatment. These results suggest that the slices can also respond to 
an inducer of TSHβ (Fig. 5). 
In summary, I visualized the TSHβ expression dynamics in the PT by using adult and neonatal TSHβLuc 
mice and observed responsiveness of the TSHβ expression to an external signal. 
 
2. Screening of candidate TSHβ upstream molecules by using TSHβ real-time monitoring system 
Screening of candidate TSHβ upstream molecules; intracellular signal transduction 
To identify upstream molecules of TSHβ mimicking light stimulation, I first screened the effects of drugs 
which perturb a candidate TSHβ-regulating pathway in the PT cells by using my real-time monitoring 
system. First, I focused on cAMP pathway mediated by G-protein coupled receptors (GPCRs). Previous 
studies have shown that the PT expresses the pertussis toxin (PTX)-sensitive MT1 GPCR. Because PTX 
is a molecule that catalyses the ADP-ribosylation of Gi family G-protein and prevents the occurrence of 
the receptor-Gi interaction (Mangmool & Kurose 2011), MT1 is thought to be the receptor coupling with 
Gi and suppress the intracellular cAMP levels. Given that TSHβ is suppressed by melatonin-MT1 
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pathway, the suppression is possibly mediated through the Gi-induced cAMP downregulation. Thus, I 
hypothesized that the elevation of intracellular levels of cAMP inversely induces TSHβ. To explore this 
possibility, I tested the effects of forskolin, an adenylate cyclase (AC) activator, on the luc signal levels in 
the PT slices. Here I tested three timing of the drug addition. First, I added the drug at the start of the 
culture. In the condition with the drug, 12 h delay of the following increase in luc activity after the 
treatment and more gradual increase in luc activity were observed compared with vehicle treatment (Fig. 
6A). Furthermore, whereas vehicle-treated slices showed two distinct peaks of luc activity (1st peak after 
26 h and 2nd peak after 44 h from starting the culture), forskolin-treated slices showed a single peak after 
56 h from starting the culture (Fig. 6A). However, no further increase of luc signals were observed. To 
mimic the in vivo condition for TSHβ induction more precisely, I next tried the 8 h-advanced lights-on 
condition (light-on 8 h after light-off), which is reported as the experimental condition of long-day 
stimulation in CBA/N mice (Fig. G5) (Masumoto et al. 2010). Because I started the culture at the timing 
of light-off (subjective ZT12), the drug were added 8 h or 8+24 h after the start of the culture. When 
forskolin was added 8 h after the start of the culture, luc activity was transiently decreased to significantly 
lower levels during the following 11 h after the drug treatment, and it eventually recovers as same level as 
vehicle treatment after 68 h from the treatment (Fig. 6B). Moreover, when forskolin was added 8+24 h 
after the start of the culture, luc activity was temporarily decreased to 0.3-fold during the following 11 h 
from the drug treatment, and then increased to 1.2-fold 40 h after the treatment compared with vehicle 
(Fig. 6C). Interestingly, these three experiments showed that the following increase in luc activity after 
forskolin treatment delays for approximately 12 h after the treatment. Furthermore, the second and third 
experiments showed the unexpected transient decrease. To rule out the possibility that competition for 
ATP between activated AC by forskolin and bioluminescence reaction of luciferase caused the transient 
decrease in apparent bioluminescence, I decided to use chemicals that stimulate downstream molecules of 
cAMP. Thus I treated the PT slices with a protein kinase A (PKA) selective agonist, 6-Bnz-cAMP (PKA 
agonist) or an exchange protein directly activated by cAMP (Epac) selective agonist, 
8-pCPT-2’-O-Me-cAMP (Epac agonist), both of which act downstream of the cAMP signal. 500 µM or 
2.5 mM of the PKA agonist induced continuous increase in luc activity compared with vehicle treatment 
and finally reached to the higher levels than vehicle treatment. Furthermore, 500 µM of Epac agonist 
increased luc activity to 1.5-fold 54 h after the treatment compared with vehicle treatment with some 
delayed peak (5 h delay from the peak in vehicle condition), although 100 µM of the compound had no 
significant effect (Fig. 6D). Taken together, I perturbed PKA or Epac signal to avoid possible competition 
for ATP, and a gradual increase in luc activity was observed by the treatment. The increased luc activity 
by 500 µM or 2.5 mM of the PKA agonist, or 500 µM of the Epac agonist treatment became higher than 
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that by vehicle treatment approximately 1.5, 2.5, or 2 days after the treatment, respectively (Fig. 6D). 
Forskolin treatment 8+24 h after the start of the culture also increased luc activity higher than vehicle 
treatment 28.5 h after the treatment (Fig. 6C). However, time-scale of induction of luc activity by these 
treatments is longer than that of TSHβ by long-day stimulation. Because long-day stimulation increased 
TSHβ expression level gradually for 8-12 h in vivo (Masumoto et al. 2010), these results suggest that 
AC-PKA pathway and AC-Epac pathway are not likely to be involved in acute TSHβ induction by 
long-day stimulation. On the other hand, the delay of increase in luc activity after the treatment was not 
observed by the PKA agonist or the Epac agonist treatment, in contrast to forskolin treatment, implying 
that PKA or Epac is not involved in the phenomenon (Fig. 6A-D). It is still unclear that why a transient 
decrease in luc activity was observed only by forskolin treatment (Fig. 6B and 6C). 
To further check the role of the cAMP signal in TSHβ expression I treated the PT slices with 
MDL-12,330A (MDL), a potent, irreversible inhibitor of AC, from the start of the culture. 1 µM or 10 µM 
of MDL treatment reduced (0.7-fold) or completely inhibited the increase of luc activity during the 
experiment, suggesting that pharmacological inactivation of AC suppressed TSHβ promoter activity (Fig. 
6E). This observation is consistent to the considering mechanism of TSHβ reduction by 
melatonin-MT1-AC inhibition pathway. However, the possibility of tissue damage by the reagent should 
be also ruled out with an additional experiment such as measuring some endogenous genes by qPCR. 
Although it seemed reasonable to hypothesize that TSHβ induction starts immediately after cAMP 
elevation, I could not find that any cAMP signal-related drugs inducing luc activity in compatible to the 
time-scale in vivo. To consider the signal hypothesis again, I next checked whether suppression of luc 
activity by melatonin treatment is PTX dependent as reported (Morgan et al. 1990). 1 µg / mL of PTX 
was added with 10 µM of melatonin 8+24 h after the start of the culture. Unexpectedly, a 1.3-fold 
increase in luc activity was observed 6.5-8 h after the treatment compared with vehicle of melatonin 
treatment (Fig. 6F). An increase in luc activity was also observed by melatonin and PTX treatment, 
suggesting that PTX treatment is unlikely to cancel the melatonin effects on luc activity. Furthermore, 
melatonin treatment 8+24 h after the start of the culture did not suppress luc activity. Note that because 
the experiment was preliminarily performed using n = 1 sample, the result should be carefully interpreted 
considering its reproducibility. To further evaluate PTX dependency of melatonin-MT1-TSHβ pathway, 
the similar experiments should be performed under TSHβ-suppressing condition by melatonin treatment 
from the start of the culture. 
I also tested the possible involvement of protein kinase C (PKC), phospolipase C (PLC), calcium ion, and 
potassium ion as TSHβ upstream cascades. 12-O-tetradecanoyl phorbol 13-acetate (TPA), a PKC 
activator, was added to PT slices 8+48 h after the start of the culture. 0.2 µM of TPA had no effects, and 
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2 µM of TPA slightly decreased luc activity. 20 µM of TPA decreased luc activity to 0.7-fold, compared 
with vehicle treatment (Fig. 7A). M-3M3FBS, a PLC activator, had also no effect when the chemical was 
added 8+48 h after the start of the culture (Fig. 7B). Treatment with a calcium ionophore ionomycin for 
30 min significantly decreased luc activity to 0.3-fold, compared with vehicle treatment (Fig. 7C). 10 mM 
of KCl treatment from the start of the culture decreased luc activity to 0.5-fold, compared with vehicle 
treatment. Further increase of KCl concentration to 60 mM, luc activity became to be significantly noisy 
(Fig. 7D). A decrease in luc activity by TPA, ionomycin and KCl treatment might be due to suppression 
of TSHβ promoter activity, or these treatments simply damaged to PT slices (Fig. 7A, C and D). Thus, 
additional experiments will be needed to distinguish these possibilities.  
In summary, I performed several screening of candidate drugs targeting for cAMP signaling, PKC, PLC, 
calcium ion, and potassium ion. There was no drug that can induce TSHβ immediately after the treatment 
as in in vivo light stimulation. 
 
Screening of candidate TSHβ upstream molecules; extracellular signal transduction 
For the next screening, I focused on molecules existing outside of PT cells. First, I checked whether 
TSHβ is fully induced only by removal of melatonin because (1) melatonin suppresses TSHβ, and (2) light 
pulse for 15 min decreased melatonin level within 45 min and melatonin is not secreted during daytime in 
vivo (Kennaway et al. 2002). 10 pM of melatonin was added to PT slices from the start of the culture, and 
was removed by medium changing after 8, 16, 24 h from starting the culture. However, luc activity was 
not recovered by the removal of melatonin at any timings (Fig. 8A). These observations suggest that only 
melatonin removal is not sufficient for TSHβ induction and thus additional molecules appears to be 
needed. 
Then I moved to search such additional molecules. First, I focused on serotonin because concentration of 
the molecule shows seasonal variation in the brain (Lambert et al. 2002). To determine whether the PT 
expresses any types of serotonin receptor subtypes, RI in situ hybridization was performed. Some of the 
serotonin receptor subtypes such as Htr1b, Htr3a, Htr5a, and Htr6 were expressed in the PT (Fig. 9A). 
Next, I checked whether serotonin induces TSHβ by using the TSHβ real-time monitoring system. PT 
slices were treated with 5, 10 or 30 µM of serotonin 8+24 h after the start of the culture. Two distinct 
peaks (2 and 13 h after serotonin treatment) of luc activity were observed and both peaks showed a 
1.2-1.3-fold increase compared with vehicle treatment (Fig. 9B). One concern is that the intrinsic 
fluorescence of serotonin is detected by PMT, because it is known that tryptophan, a precursor of 
serotonin, has a fluorescence property. To rule out this possibility, I assessed the effects of the intrinsic 
fluorescence of serotonin in this real-time monitoring system. Indeed, serotonin treatment increased raw 
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photon counts in a dose-dependent manner. 10 µM and 30 µM of serotonin addition to neonatal PT slices 
from CD-1 mice that do not carry luc reporter increased raw photon counts to 1.25-fold and 1.5-fold, 
respectively (Fig. 9C). These results suggest that the intrinsic fluorescence of serotonin can be detected 
by PMT and distinguishing between the serotonin’s intrinsic fluorescence and an increase in luc activity 
by serotonin treatment is difficult. To further analyze the serotonin effects on TSHβ expression, I 
examined whether serotonin induces TSHβ in the PT in vivo. 3-week-old CBA/N mice kept under 
short-day conditions were chronically administrated fluoxetine (10 or 22 mg/kg/day) or paroxetine (10 or 
30 mg/kg/day), two representative selective serotonin reuptake inhibitors (SSRIs), for 2 weeks. I 
evaluated the effects of SSRIs on TSHβ expression levels in the PT by RI in situ hybridization, and I did 
not find any significant difference (Fig. 9D). These results indicate that serotonin is not likely to have a 
role on TSHβ induction. 
Next, I focused on GPCRs expressed specifically in the PT region. I hypothesized that some GPCRs 
competing with MT1 might induce TSHβ. Here I screened for candidate GPCRs expressed in the median 
eminence (ME) region including the PT from Brainstars, a quantitative expression database of the adult 
mouse brain including genome-wide expression profile at 51 adult mouse central nervous system regions 
(Kasukawa et al. 2011). TSH receptor (Tshr), sphingosine-1-phosphate receptor-3 (S1pr3), 
cysteinyl-leukotriene type-1 receptor (Cysltr1), and frizzled-5 (Fzd5) were picked up as candidate GPCRs. 
In addition, MT1 (Mtnr1a) was also picked up by this screening, suggesting that this screening is 
functional for picking up candidate GPCRs in the PT. Expression patterns of these candidate genes were 
analyzed by RI in situ hybridization, and Mtnr1a, Tshr, and Fzd5 were indeed expressed in the PT (Fig. 
10A), consistent with previous studies reporting that Mtnr1a and Tshr were expressed in the mouse PT 
(Roca et al. 1996; Ono et al. 2008; Unfried et al. 2009). In contrast, S1pr3 and Cysltr1 expression were 
not detected in the PT (Fig. 10A). Thus, I tested the possibility of positive feedback by TSHβ itself. PT 
slices were treated with 1 or 10 mIU/mL of TSH from the start of the culture, but no effect on luc activity 
was observed (Fig. 10B). 
An output molecule from the SCN that controls circadian clock was also examined because 
photoperiodism is based on circadian rhythms. Prokineticin 2 (Pk2) is reported as output molecule of the 
SCN, and administration of PK2 altered wheel-running activity in rats (Cheng et al. 2002). 20 nM of 
recombinant PK2 treatment 8+48 h after the start of the culture did not alter luc activity in PT slices (Fig. 
11A). Furthermore, prokineticin receptor 2 (Pkr2) was not expressed in the PT (Fig. 11B). These results 
indicate that PK2-PKR2 pathway is unlikely to be involved in TSHβ induction. 
Glutamic acid, one of excitatory neurotransmitters, is a candidate upstream molecule of TSHβ-inducible 
signals. It was reported that glutamic acid induces the TSHβ expression in the rat PT (Aizawa et al. 2012). 
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Furthermore, a transient increase in luc activity was observed by glutamic acid treatment by using TSHβ 
real-time monitoring system (Fig. 5). Therefore, I tested whether glutamic acid receptor agonists can 
induce TSHβ. PT slices were treated with 50 µM of kainic acid (KA), 50 µM of 
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), or 50 µM of N-methyl-D-aspartic 
acid (NMDA) after 2 h of glutamine and glutamic acid starvation, resulting in no changes in luc activity 
were observed (Fig. 12).  
Taken together, among candidate extracellular molecules for which I performed screening in this study, I 
did not find any TSHβ-inducible signals except glutamic acid. 
 
3. Analysis of time dependency in TSHβ induction by using TSHβ real-time monitoring system 
Analysis of time dependency in luc activity in response to melatonin removal and forskolin treatment 
It is believed that light stimuli at specific time can induce photopeperiodic responses (gating mechanism) 
because photoperiodism is based on circadian clock (Bünning 1936; Ravault & Ortavant 1997). Our 
group previously showed that light stimulation at the subjective late night can rapidly induce TSHβ in the 
mouse PT, suggesting that the timing of light stimulation is important for TSHβ induction (Masumoto et 
al. 2010). Thus, I examined whether TSHβ is induced by the treatment at a specific timing. First, I 
hypothesized that a decrease in melatonin levels by light stimulation at a specific time induces TSHβ. 
However, three different timings of melatonin removal did not alter luc activity of PT slices (Fig. 8A). To 
check the possibility that not only melatonin removal but also another stimulation is necessary for TSHβ 
induction, melatonin was removed and forskolin was applied to PT slice. PT slices were treated with 10 
pM of melatonin from the start of the culture and melatonin was removed 8, 16, and 24 h after the start of 
the culture. At the same time, 1 µM of forskolin was applied to PT slices. These treatments decreased luc 
activity transiently for approximately 12 h after treatments and a following increase in luc activity was 
observed. (Fig. 8B). Removal of melatonin with/without forskolin treatment did not induce luc activity 
immediately after the treatment. These observations suggest that TSHβ response to melatonin removal 
and forskolin does not have time-dependency in this experimental condition. 
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Discussion 
In the present study, I established a TSHβ real-time monitoring system in which the TSHβ expression 
dynamics can be monitored as real-time bioluminescence activities. The difference in luc activity of PT 
slices derived from adult mice under short- or long-day conditions was consistent with in vivo TSHβ 
expression levels in response to each day-length condition (Fig. 2, 3B). Moreover, the luc activities of 
adult and neonatal PT slices were suppressed by melatonin treatment (Fig. 3C,E). I also observed 
dose-dependent suppression of TSHβ in neonatal PT slices by melatonin (Fig. 3E) at physiological levels 
(Kennaway et al. 2002), which is consistent with the results using ovine PT cell cultures (Morgan et al. 
1989). Furthermore, the luc activities were transiently up-regulated by glutamic acid treatment as seen in 
the rat PT (Aizawa et al. 2012) (Fig. 5). These observations suggest that PT slices possess at least TSHβ 
responsiveness to melatonin and glutamic acid, and changes in TSHβ expression dynamics under other 
stimuli are also expected to be observed by using my monitoring system. Furthermore, I performed 
preliminary screening for candidate upstream molecules of TSHβ, however, I did not find any 
intracellular or extracellular molecules that upregulate luc activity except glutamic acid in this study. 
Chronic melatonin treatment in this monitoring system may not necessarily the same as physiological 
conditions, comparing with nocturnal melatonin secretion in vivo. However, because TSHβ was induced 
within several hours after long-day stimulation in vivo, this monitoring system is at least available for 
screening of candidate molecules upstream of TSHβ, by observing luc activity during the same period. 
Transiently increased luc activity by glutamic acid treatment supports this idea (Fig. 5). 
Some observations and experimental conditions were not consistent with in vivo conditions. First, several 
studies show that melatonin implantation (constant release of melatonin) has no effect on testicular 
regression in hamsters (Goldman et al. 1979). Furthermore, melatonin injection under long-day 
conditions does not suppress TSHβ expression for at least 4 days in hamster (Yasuo et al. 2010), which is 
inconsistent with the immediate suppression presented in Fig. 3C. I speculate that difference between 
these in vivo observations and my in vitro results may be due to experimental conditions such as existence 
of TSHβ-inducible signals. Second, melatonin decreased luc activity and the activity was not recovered 
for the following 2-3 days after melatonin removal (Fig. 8A). Melatonin is lipophilic, implying that it is 
almost impossible to remove them completely by medium changing. Melatonin may be remained in the 
PT slices after medium changing. Furthermore, Cytochrome P450 1A2 (CYP1A2), which degrades 
melatonin in the liver, seems not be exist in PT slices because Cyp1a2 is not expressed in the ME region 
(Kasukawa et al. 2011; Choudhary et al. 2011). Third, I added drugs to PT slices without following 
removal of drugs except ionomycin treatment (Fig. 7C). Although a drug treatment for a long time is 
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different form physiological conditions, a transient drug treatment such as ionomycin treatment will more 
precisely mimic in vivo conditions. Fourth, I observed a significant decrease in luc activity for 
approximately 12 h after the start of the culture. One possibility is that the PT clock was reset by PT slice 
preparation. Another possibility is that TSHβ-inducible signals in vivo were lost by preparation. 
Measuring some endogenous expressions of circadian clock genes by qPCR will reveal the effect of slice 
preparation on the PT clock. Therefore, careful design of experiments will be necessary in each purpose. 
One possible application of my experimental system is to screen upstream light information signals of the 
TSHβ induction. My system has several advantages for this purpose: (i) The PT slices can be used and 
easily treated with drugs compared with previous methods such as subcutaneous injection (Yasuo et al. 
2007), intracerebroventricular injection (Ono et al. 2008) or dissociated PT cells (Morgan et al. 1989), (ii) 
availability of neonatal tissues increases the throughput of the experiment and viability of the slices. 
Previous reports support that neonatal PT has the similar photoperiodic properties to adult PT. First, high 
expression levels of TSHβ (Schulze-Bonhage & Wittkowski 1990; Japon et al. 1994), MT1 receptor 
(Williams et al. 1991; Johnston et al. 2003) and rhythmic expression of the clockwork genes (Ansari et al. 
2009) were observed in both embryonic and neonatal PT. Second, fetal and neonatal lambs showed 
changes in prolactin concentration in response to day-length (Ebling et al. 1988; Ebling et al. 1989). 
I performed screening for candidate upstream molecules of TSHβ. Cyclic AMP was a candidate 
TSHβ-inducible molecule because MT1 is reported to be Gi-coupled receptor. Forskolin, PKA agonist, or 
Epac agonist treatment increased luc activity more gradually compared with vehicle treatment, and 
time-scale of induction was inconsistent with the case of light stimuli in vivo (Fig. 6A-D). An increase in 
luc activity by cAMP elevation had been initially expected to start immediately after the treatment 
because light pulse for 15 min suppresses pineal melatonin and plasma melatonin concentrations to basal 
levels within 45 min from the start of light exposure (Kennaway et al. 2002). Thus, the inconsistency 
suggests that cAMP signal is not likely to be involved in acute TSHβ induction. On the other hand, it is 
reported that TSHβ expression level under long-day conditions for 2 weeks was higher than that in the 
first long-day (Masumoto et al. 2010). Thus, cAMP signaling may be involved in a gradual increase 
and/or maintenance of TSHβ expression after acute induction of TSHβ by long-day stimulation. 
Unexpectedly, forskolin treatment during the culture caused a transient decrease in luc activity (Fig. 6B 
and C). One interpretation for the phenomenon is that competition for ATP between activated AC by 
forskolin and bioluminescence reaction of luciferase caused the transient decrease in apparent 
bioluminescence. Another interpretation is that a transient decrease in luc activity may due to acute 
induction of negative regulators by forskolin treatment. For example, it is reported that forskolin induced 
Per1 immediately in fibroblasts (Balsalobre et al. 2000; Yagita & Okamura 2000) and Per1 reduced the 
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Bmal1-Clock-induced TSHβ promoter activity in in vitro TSHβ promoter assay (Unfried et al. 2009). On 
the other hand, forskolin treatment at the start of the culture just delayed the increase in luc activity and 
did not decrease it compared with vehicle treatment (Fig. 6A). The decrease in luc activity by forskolin 
treatment at this timing may be masked because the significant decrease in luc activity for first 12 h was 
also observed by vehicle treatment. Furthermore, the observed delay of the increase in luc activity may 
possibly be due to resetting of the PT clock by forskolin treatment. Several previous reports support this 
idea. First, forskolin resets expression patterns of circadian clock genes in various tissues including the 
SCN (Prosser & Gillette 1989; Yagita & Okamura 2000; Abe et al. 2002; Izumo et al. 2006). Second, 
circadian clock genes or PER2::LUC monitoring molecule are expressed and oscillating in the PT or the 
median eminence/pars tuberalis region, respectively (Ansari et al. 2009; Guilding et al. 2009; Masumoto 
et al. 2010). Third, some reports indicate that circadian clock genes control TSHβ expression in in vitro 
TSHβ promoter assay (Unfried et al. 2009; Masumoto et al. 2010). To further check whether forskolin 
reset the PT clock in future studies, a possible way is monitoring the spatial pattern of the 
bioluminescence activity in PT slices from PER2::LUC knock-in mice with a macrozoom microscope and 
a CCD camera (Yoo et al. 2004), with or without forskolin treatment. Interestingly, PKA agonist or Epac 
agonist treatment that act downstream of AC did not cause the delay of increase in luc activity after the 
treatment (Fig. 6D), suggesting that the observed delay is possibly due to AC activation. Furthermore, 
whether melatonin-MT1-TSHβ pathway is mediated by the Gi-coupled receptor and antagonizes the 
cAMP signal should be checked carefully. When melatonin was added to the PT slices with a Gi inhibitor 
PTX, the pattern of luc activity by melatonin treatment was not canceled (Fig. 6F). To further explore the 
possibility of cAMP involvement in TSHβ induction, I think it is necessary to observe the response of the 
signal to day-length change in vivo. I also performed experiments about other signaling pathway such as 
PKC, PLC, calcium ion, and potassium ion to screen candidate TSHβ upstream cascades, any upregulator 
of luc activity was not found in this study (Fig. 7). Other drug treatments that act different action points 
and identification of the detailed signaling of melatonin-MT1-TSHβ pathway are important in future. One 
candidate signaling involved in melatonin-MT1-TSHβ pathway is the Gq/11 pathway. It is reported that 
human MT1 functionally couples with Gi and Gq/11 proteins by coprecipitation experiments (Brydon et al. 
1999). Treating the PT slices with melatonin and YM254890, a Gq/11 inhibitor, will reveal whether 
melatonin-MT1-TSHβ pathway is dependent on the Gq/11 pathway. Moreover, other drugs targeting the 
Gq/11 pathway such as U73122 (a PLC inhibitor), bryostatin 1 (a PKC activator), and C-1 (a PKC 
inhibitor) will help to reveal a role of the Gq/11 pathway on TSHβ induction. Meanwhile, because 
melatonin removal from the PT slice culture medium did not alter luc activity suppressed by melatonin, 
other TSHβ-inducible signals seem to highly exist (Fig. 8A). The screening of candidate TSHβ upstream 
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molecules existing outside of the PT cells was performed. First, I tested the effects of serotonin that 
shows seasonal variation in the brain. Although some of serotonin receptor subtypes were expressed in 
the PT, serotonin administration did not alter TSHβ in vivo (Fig. 9A and D). Second, I focused on GPCRs 
expressed specifically in the PT region and possibly competing with MT1. I confirmed that Mtnr1a, Tshr, 
and Fzd5 were expressed in the PT. However, TSH did not increase luc activity (Fig. 10). Other candidate 
GPCR was Fzd5, the receptor for Wnt5a ligand (Tanaka et al. 1998; Ishikawa et al. 2001). The 
involvement of Wnt5a-Fzd5 pathway in TSHβ induction should be examined in the future. Third, PK2, an 
output molecule from the SCN was examined because photoperiodism is based on circadian clock. 
However, Pkr2, the receptor of PK2, was not expressed in the PT and PK2 did not have any effects on luc 
activity (Fig. 11). Finally, I checked whether glutamic receptor agonists can induce TSHβ because a 
transient increase in luc activity was observed by glutamic acid treatment (Fig. 5). However, KA, AMPA, 
or NMDA did not alter luc activity (Fig. 12). Collectively, I could not find any TSHβ-inducible signals 
except glutamic acid. These results suggest that glutamic acid is one of TSHβ-inducible signals. Note that 
glutamic acid induces luc activity weakly, implying that other TSHβ-inducible signals are necessary for 
efficient induction of TSHβ. For example, transforming growth factor alpha (TGFα), cardiotrophin-like 
cytokine (CLC), and vasoactive intestinal peptide (VIP), which are reported as output molecule of the 
SCN and alter circadian rhythms of behavior or hormone (Harney et al. 1996; Kramer et al. 2001; Kraves 
& Weitz 2006), and neurotransmitters of avian deep brain photoreceptors are candidates of 
TSHβ-inducible signals (Halford et al. 2009; Nakane et al. 2010; Yamashita et al. 2010). Unfortunately, 
neurotransmitters of avian deep brain photoreceptors have been unidentified yet. I hope neurotransmitters 
of avian deep brain photoreceptors will be identified because Opsin-5, one of deep brain photoreceptors, 
is suggested to be involved in TSHβ induction in Japanese quails (Nakane et al. 2014). Furthermore, 
comprehensive analysis of gene expression patterns in the PT immediately after long-day stimulation will 
reveal acute response genes to long-day stimulation, and information of these genes may provide hints for 
candidate TSHβ upstream molecules. 
My system is also applicable to investigate the mechanism of photoinducible phase (gating), by which the 
response of the PT to a light signal including TSHβ induction is gated during the late night (Masumoto et 
al. 2010). Internal circadian time is probably involved in the determination of the gate timing, because 
photoperiodic responses can be induced by light stimuli at specific time (Ravault & Ortavant 1997). Thus, 
I checked time-dependency of TSHβ responsiveness by different timings of treatment such as melatonin 
removal and forskolin treatment (Fig. 8). Melatonin removal alone at different timings did not recover 
suppressed luc activity. Melatonin removal plus forskolin treatment at different timings decreased luc 
activity transiently and a following gradual increase was observed. These results imply that melatonin 
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removal and forskolin treatment are not likely to have time-dependency in TSHβ responsiveness and 
forskolin may possibly reset the PT clock in this experimental condition. Treatment with a 
TSHβ-inducible molecule that does not affect the PT clock is important to test for time-dependency of 
TSHβ responsiveness. Besides, analysis of the relationship between circadian clock genes and TSHβ will 
also provide hints for the gating mechanism. It is reported that several circadian clock genes and circadian 
clock-controlled genes regulate TSHβ promoter activity by in vitro TSHβ promoter assay (Unfried et al. 
2009; Masumoto et al. 2010). Thus, similar experiments using the PT slices from mice generated by 
mating TSHβLuc mice with knockout mice of circadian clock genes will help to reveal the detailed 
relationship between circadian clock genes and TSHβ. Furthermore, it is also important to understand the 
molecular mechanism of the PT clock by using the PT slices from PER2::LUC knock-in mice, because 
rhythmic expression of circadian clock genes in the PT is melatonin-dependent and this property is 
different from the SCN clock. 
The TSHβLuc mice generated here are the first report of TSHβ null mice. TSHβLuc mice enabled us to study 
the photoperiodic roles of TSHβ. Although TSHβ is also expressed in the pituitary and functions as a part 
of the hypothalamus–pituitary–thyroid (HPT) axis, it is believed that the molecule in the PT acts 
differently from the HPT axis. This idea is supported by the results that TSHβ expression in ovine PT did 
not change with thyroid-releasing hormone (TRH) and thyroid hormone (TH) treatment, because the lack 
of TRH and TH receptor or transcription factor Pit-1 induces TSHβ in the pituitary (Bockmann et al. 
1997). Growth retardation observed in homozygous TSHβLuc mice (Fig. 1D) is consistent with previous 
observations in hypothyroid mice, such as TSHR knockout mice (Marians et al. 2002), the Snell dwarf 
mice (Cordier et al. 1976), the cog mice (Taylor & Rowe 1987) and the hyt mice (Beamer et al. 1981), 
and could be recovered by supplementation with thyroid powder (Fig. 1D). Thus, photoperiodic 
phenotypes in the TSHβLuc mice, if any, can be discriminated from the effects of the impaired HPT axis 
by supplementation with thyroid powder. Because no obvious photoperiodic phenotype has not been 
identified in laboratory mice, such as testicular growth, which is a typical photoperiodic phenotype (Ono 
et al. 2008), it will be intriguing to further explore photoperiodic phenotypes in laboratory mice with 
reference to known seasonal physiological changes such as gonad growth in female European hamsters 
(Hanon et al. 2010), metabolic changes such as adipose depot mass and serum leptin (Atcha et al. 2000) 
and immune system such as NK cell cytolytic activity and phagocytosis in Siberian hamsters (Yellon et al. 
1999; Martin et al. 2008). Even if no obvious photoperiodic phenotype can be identified in laboratory 
mice, molecular mechanisms underlying the induction of TSHβ by long-day light exposure are 
evolutionary conserved (Hanon et al. 2008; Nakao et al. 2008; Ono et al. 2008; Dardente et al. 2010; 
Dupre et al. 2010; Hanon et al. 2010; Masumoto et al. 2010; Yasuo et al. 2010). Therefore, TSHβLuc mice, 
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established in this study, will provide useful insights into the evolutionary conserved molecular 
mechanism of photoperiodism. 
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Conclusion 
In this thesis, I established an experimental system for screening candidate upstream molecules of TSHβ. 
I generated a genetic mouse model in which TSHβ expression dynamics in the PT can be visualized by 
bioluminescence. In the mouse strain, a part of coding sequence of TSHβ was replaced by Luc gene and 
thus the luc activity represents direct transcription from the endogenous TSHβ promoter. Animals were 
backcrossed and maintained on a CBA/N background and I found that phenotypes of heterozygous 
TSHβLuc mice were comparable with those of wild-type mice, whereas homozygous TSHβLuc mice showed 
growth retardation. I also confirmed that the Luc expression represented the physiological photoperiodic 
responses of TSHβ in the PT and did not affect the expressions of endogenous TSHβ and Cga by in situ 
hybridization of TSHβLuc mice exposed to short-day or long-day conditions. I prepared brain slices 
including PT regions from TSHβLuc mice and bioluminescence activity was observed only in the putative 
PT region. Treatment of cultured PT slices with melatonin decreased bioluminescence activities, 
endogenous TSHβ expression and secreted TSH protein in the cultured medium. These results showed 
that PT slices can response to melatonin in our culture condition. Thus, my mouse model could be used to 
search for molecules that relay external light signals in the PT. Furthermore, I performed preliminary 
screening for candidate upstream molecules of TSHβ such as drugs targeting the intracellular signaling 
pathways, hormones, and so on, and I found that glutamic acid is a strong candidate of TSHβ-inducible 
molecules in this study. Unexpectedly, activators of cAMP-related molecules did not increase 
bioluminescence activities immediately after the treatment as seen in TSHβ induction in vivo. 
Identification of upstream molecules of TSHβ is one of the next attractive issues. I hope the knowledge 
obtained in this study will provide the clues to comprehend the mechanism for day-length measurements 
in mammalian photoperiodism. 
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Experimental procedures 
Generation of TSHβLuc mice 
TSHβLuc mice [Tshb(Luc); Acc. No. CDB0713K: 
http://www.cdb.riken.jp/arg/mutant%20mice%20list.html] were generated as follows: a 1.9 kbp of Luc 
cassette that contains Luciferase (Luc)-coding region and simian virus 40 polyadenylation signal was 
amplified by PCR from pGL4.10 (Promega, Madison, WI, USA) using Luc-F-EcoRI 
(5′-AGAATTCTACTGTTGGTAAAGCCACCATGGAAGAT-3′) and Luc-R-NotI 
(5′-CGGAGCGGCCGCGATTTTACCACATTTGTAGAGGTTTTACTTGC- 3′) primers (Hokkaido 
System Science, Sapporo, Japan). The amplified product was ligated into the EcoRI/NotI site of 
pBluescript SK (−) (Stratagene, La Jolla, CA, USA). The 6.3-kb 5′-arm was PCR-amplified from a 
bacterial artificial chromosome (BAC) clone containing TSHβ (RP24-230F23; BACPAC Resources, 
Oakland, CA, USA) using 5-F-SalI 
(5′-GCAGGTCGACCAATAGAGGGAACAGAATAGTCCCAAACG- 3′) and 5-R-BsmBI 
(5′-ACGGCGTCTCTCATGCTGAATCAGAGAGAAACATCAAAGAGCTC-3′) primers, and the 
amplicon was ligated into the SalI/ NcoI site upstream of the Luc of pBluescript SK (−) to make the 5′ 
arm-Luc cassette, in which the Luc cassette was connected in frame to the first ATG of the TSHβ gene. 
The 5′ arm-Luc cassette was inserted into the SalI/NotI site of the PGK-Neo-pA/DT-A vector (detailed 
descriptions of the vector are available from http://www.cdb.riken.go.jp/arg/cassette. html). The 2.8-kbp 
3′-arm was also PCR-amplified from the BAC clone using 3-F-AvrII 
(5′-GACCCTAGGATGTTGTTCAATGCATTTCTTTTAGCTGTAA-3′) and 3-R-SalI 
(5′-ATTAGTCGACGTACCATGCTATGCTGTTAACCTGCAATAC-3′) primers, and the amplicon was 
ligated into the XbaI/XhoI site of the PGK-Neo-pA/DT-A vector. The resultant targeting vector was 
linearized with the AscI site and introduced into TT2 embryonic stem cells by electroporation (Yagi et al. 
1993; Murata et al. 2004). Screening of homologous recombinant embryonic stem cells and production of 
chimera mice are described elsewhere (http://www.cdb.riken.jp/arg/Methods.html). PCR primers used to 
routinely identify the wild-type allele are P1 (5′-CGCAGGGCCCAGGGATAAGTAACCAGTCAG-3′) 
and P2 (5′-ACCCGTGTCATACAATACCCAGCACAGATGGTG-3′); those to identify the mutant allele 
are P1 (5′-CGCAGGGCCCAGGGATAAGTAACCAGTCAG-3′) and P3 
(5′-ACAGCCACACCGATGAACAGGGCACCCAAC-3′) (Fig. 1A). PCR products of 305 and 446 bp 
were derived from wild-type and mutant alleles, respectively. For Southern blot analysis, genomic DNA 
extracted from ES cells or a mouse tail was digested with AvrII, and resulted bands were detected with 
radioactive probes (14.5- and 18-kbp bands from wild-type and mutant alleles, respectively, in Fig. 1A). 
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Many laboratory mouse strains such as C57BL/6 lack melatonin production ability because of natural 
knockdown of the serotonin N-acetyltransferase (AANAT) activity (Roseboom et al. 1998) and low 
expression levels of hydroxyindole O-methyltransferase (HIOMT) protein (Kasahara et al. 2010; 
Shimomura et al. 2010), which are rate-limiting enzymes for melatonin synthesis. By contrast, CBA/N 
mice are melatonin proficient and they show significant TSHβ induction after long-day stimulation (Ono 
et al. 2008; Masumoto et al. 2010). Thus, TSHβLuc mice were backcrossed for more than 10 generations 
and maintained on a CBA/N background for all experiments except the measurement of growth in Fig. 
1D (more than four generations). 
 
Animals 
Mice were carefully kept and handled according to the RIKEN Regulations for Animal Experiments. For 
in situ hybridization experiments, L12 : D12 conditioned male 3-week-old wild-type and heterozygous 
TSHβLuc mice were housed under short-day conditions (L8 : D16, 400 lux) or under long-day conditions 
(L16 : D8, 400 lux) for 3 weeks. L12 : D12 conditioned male 3-week-old CBA/N mice (SLC Japan, 
Shizuoka, Japan) were housed under long-day conditions (L16 : D8, 400 lux) for 3 weeks in Fig. 9A, 10A, 
and 11B. 
For neonatal PT slice culture experiments except Fig. 7A, neonatal wild-type and heterozygous TSHβLuc 
mice were generated by overnight breeding of heterozygous TSHβLuc and CBA/N mice. In Fig. 7A, 
neonatal wild-type and heterozygous TSHβLuc mice were generated by in vitro fertilization (IVF) of 
heterozygous TSHβLuc and CBA/N mice. Pregnant mice and pups were housed under L12 : D12 
conditions (400 lux) because it was reported that exposure to different light/dark conditions from birth 
affects circadian properties (Ciarleglio et al. 2011). For adult PT slice culture experiments, L12 : D12 
conditioned 3-week-old wild-type and heterozygous TSHβLuc mice were housed under short- or long-day 
conditions for 2 to 3 weeks. For other experiments, TSHβLuc mice were housed under L12 : D12 
conditions. All mice were given commercial chow and water ad libitum except the supplementation of 
thyroid powder experiment. Homozygous TSHβLuc mice were given commercial chow with 100 ppm 
thyroid powder (Sigma, St. Louis, MO, USA) and water ad libitum (Fig. 1D). 
 
In situ hybridization 
Mice were deeply anesthetized with isoflurane (Mylan, Tokyo, Japan) and intracardially perfused with 10 
mL saline and 20 mL of a fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 
7.4. Mouse brain samples were post-fixed in the same fixative for 24 h at 4 °C, soaked in PB containing 
20% sucrose for several days and stored frozen at −80 °C for further use. In situ hybridization was carried 
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out as previously described (Shigeyoshi et al. 1997; Masumoto et al. 2010). Serial coronal sections (40 
µm thick) of the mouse brain were prepared using a cryostat (CM 1850; Leica Microsystems, Wetzlar, 
Germany). To prepare probes, fragments of cDNA were obtained by PCR and subcloned into the 
pGEM-T easy vector (Promega). Radiolabeled probes were generated using 35S-UTP (PerkinElmer, 
Norwalk, CT, USA) via a standard protocol for cRNA synthesis. The primers used in the construction of 
in situ hybridization cRNA probes were as follows:  
TSHβ cRNA probe: 
Forward primer: 5′-TGGGTGGAGAAGAGTGAGCG-3′ 
Reverse primer: 5′-ACCAGATTGCACTGCTATTG-3′ 
Cga cRNA probe: 
Forward primer: 5′-GCAGGCACTGAAAAATCCAGAGACATTGTTC-3′ 
Reverse primer: 5′-ACACACAGCGCCATTGAATGGCTC-3′ 
Luc cRNA probe: 
Forward primer: 5′-CACCGGTAAGACACTGGGTGTGAACCAGC-3′ 
Reverse primer: 5′-CACGGCGATCTTGCCGCCCTTCTTGGC-3′ 
Htr1a cRNA probe: 
Forward primer: 5′-TCCCAGCCAAGTCAGCCCCCAAATTCTG-3′ 
Reverse primer: 5′-CCCTGTCAGTCTCTCAGGTGTGGACACC-3′ 
Htr1b cRNA probe: 
Forward primer: 5′-ATGCTGGACTGCTTTGTGAACACCGACC-3′ 
Reverse primer: 5′-GGGGTTGATGAGGGAGTTAAGATAGCCTAACC-3′ 
Htr1d cRNA probe: 
Forward primer: 5′-AGCTAGGTCACTGTGTTGTGTAAAGGGGAG-3′ 
Reverse primer: 5′-AATAGGGTGTCCCATTCAAAGCCTCGAGTG-3′ 
Htr1f cRNA probe: 
Forward primer: 5′-TACAGAGCAGCAAGGACACTGTACCAC-3′ 
Reverse primer: 5′-ATCCTAATATCGGCATCGTACAAGTTTTTGG-3′ 
Htr2a cRNA probe: 
Forward primer: 5′-AAGCCGCTGCAGTTAATTTTAGTGAACAC-3′ 
Reverse primer: 5′-GTCACCAACTTACTCCCATGCTACCCATC-3′ 
Htr2b cRNA probe: 
Forward primer: 5′-AGATTTGCTGGTTGGATTGTTTGTGATGC-3′ 
Reverse primer: 5′-AAAACTGTGGGCACAGTCCACCGTGTTAG-3′ 
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Htr2c cRNA probe: 
Forward primer: 5′-TCTTAACTATCAGGGCAAGCTCATAGCAC-3′ 
Reverse primer: 5′-CTCAGAAGAAGGTAATACACAGGAATAAG-3′ 
Htr3a cRNA probe: 
Forward primer: 5′-TGCTGGCTGTGCTCGCTTACAGCATCACC-3′ 
Reverse primer: 5′-CCTGCTCCCATTGGCTGATGAAGCTGAG-3′ 
Htr3b cRNA probe: 
Forward primer: 5′-GCAGCAACTGCGTACACTTAGGTTTAAGG-3′ 
Reverse primer: 5′-ACACCCCCTGCTTTAAATAAGGCAAACTG-3′ 
Htr4 cRNA probe: 
Forward primer: 5′-GTGGACCAATGTATGAATGGCCAGCTGAC-3′ 
Reverse primer: 5′-CAGTTTAAAAACAAAACCTGTGAAGGTCCCTGTG-3′ 
Htr5a cRNA probe: 
Forward primer: 5′-GACTGTGGACATGTTTCATGTTGATTCCTG-3′ 
Reverse primer: 5′-CCTAGAGACGGTGTTACATGTGGTTATGC-3′ 
Htr5b cRNA probe: 
Forward primer: 5′-ACGGCCCGATGATGACACTCCAAAAGTC-3′ 
Reverse primer: 5′-TACGTGTGTCTCCATCAAAAGCAGGCCAC-3′ 
Htr6 cRNA probe: 
Forward primer: 5′-GCCGTATGTGACTGCATCTCTCCAGGTCTC-3′ 
Reverse primer: 5′-TCTTGACCTGGTCAGTTCATGGGGGAACC-3′ 
Htr7 cRNA probe: 
Forward primer: 5′-CTCTGGAACACCATTCTGTTTCATGTGGAG-3′ 
Reverse primer: 5′-TACGTTCACTCTAGCGAATCTGCAGCTCAGG-3′ 
Tshr cRNA probe: 
Forward primer: 5′-CAACGATGAAGTAGCCCAGAGGGTCC-3′ 
Reverse primer: 5′-GGACCGAAGTCATGTAAGGGTTGTCTGTG-3′ 
Fzd5 cRNA probe: 
Forward primer: 5′-GAGAGAGAGAGATTTAGTGACTTTTGATACGGG-3′ 
Reverse primer: 5′-GACATTTCTTTGTTTTTCATAAATAACTAATCTCC-3′ 
S1pr3 cRNA probe: 
Forward primer: 5′-CACCATCCCCAGCTAGGAGGTGACATTTGTAG-3′ 
Reverse primer: 5′-CAATCTAACATCATCTACAAGATGGCCCTGGGGG-3′ 
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Cysltr1 cRNA probe: 
Forward primer: 5′-TGCTTTGAGCCTCCACAGAACAATCAAGC-3′ 
Reverse primer: 5′-CGTTACATATTTCTTCTCCTTTTTCTGGCAAGG-3′ 
Mtnr1a cRNA probe: 
Forward primer: 5′-CGGCTCGATATTCAACATCACGGGGATC-3′ 
Reverse primer: 5′-GCAGCTGTTGAAGTACGCCAGGTAGTAAC-3′ 
Pkr2 cRNA probe: 
Forward primer: 5′-CCTTCAGGTGTTGCCCAAGGAAAAATTTAAC-3′ 
Reverse primer: 5′-CATTCTTCACAAAGGAAGAGGTGAAAATCACATCC-3′ 
 
PT slice culture 
TSHβLuc mice were decapitated 1–4 h before lights-off (ZT12 for neonatal PT slices, ZT8 or 16 for adult 
short- or long-day slices). PT slices were prepared from neonatal pups (6–8 days old) or adult mice (5 to 6 
weeks old). For neonatal PT slice culture experiments, brains were rapidly removed and were cut by a 
tissue chopper (McIlwain Tissue Chopper; McIlwain Laboratory Engineering, Gomshall, Surrey, UK) to 
a thickness of 350 µm. For adult PT slice culture experiments, brains were rapidly removed and were cut 
by a vibratome type linearslicer (PRO7; Dosaka EM, Kyoto, Japan) to a thickness of 300 µm. The PT 
region slices were dissected using a surgical knife. The slices were then placed on a culture membrane 
(MilliCell-CM; Millipore, Bedford, MA, USA) and set on a dish with 1.2 mL culture medium containing 
DMEM/F12 (Invitrogen, Carlsbad, CA, USA) supplemented with 300 mg/L NaHCO3 (Sigma), 20 mg/L 
kanamycin (Invitrogen), 100 mg/L apo-transferrin (Sigma), 100 µM putrescine (Sigma), 20 nM 
progesterone (Sigma), 30 nM sodium selenite (Sigma) and 1 mM luciferin (Biosynth, Staad, Switzerland). 
In Fig. 7A, B and 11A, 5mg/L insulin (Sigma) was applied to the above medium because experimental 
condition was not fixed in these stages. The dish was sealed with silicone grease (HVG; Dow 
Corning-Toray, Tokyo, Japan). Explants from different pups were cultured separately, and only those of 
appropriate genotypes were chosen for further experiments. Slices were treated with reagents as specified 
in each experiment. Reagents were obtained from the following sources: forskolin, gulutamine, glutamic 
acid, 6-Bnz-cAMP (PKA agonist), MDL-12,330A (MDL), pertussis toxin (PTX), m-3M3FBS, 
12-O-tetradecanoyl phorbol 13-acetate (TPA), KCl, serotonin, 
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), N-methyl-D-aspartic acid 
(NMDA), kainic acid (KA), and TSH from bovine pituitary from Sigma; 8-pCPT-2′-O-Me-cAMP (Epac 
agonist) from Biolog (Bremen, Germany); recombinant prokineticin 2 was kindly provided by Dr. Zhou. 
Reagents were solubilized in water, ethanol or dimethylsulfoxide (DMSO) to make stock solutions 
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40-1000x the working solutions. Serotonin was solubilized in 0.1 N HCl. Kainic acid was solubilized in 
1N NaOH and adjusted to the appropriate volume by the addition of water. Glutamine, glutamic acid, 
serotonin, AMPA, NMDA, and KA aliquots were made fresh each day. For glutamine and glutamic acid 
starvation, culture medium with DMEM/F12 without glutamine and glutamic acid (Cell Science & 
Technology Institute, Sendai, Japan) was used. For glutamine, glutamic acid, AMPA, NMDA, or KA 
treatments, the glutamine- and glutamic acid–starved culture medium was replaced with the above fresh 
culture medium or with added vehicle, glutamine, glutamic acid, AMPA, NMDA, or KA (Fig. 5, 12). For 
ionomycin treatment, PT slices on culture membranes were transferred to other dishes containing fresh 
medium with ionomycin for 30 min. PT slices on culture membranes were returned to the previous dishes 
and the dishes were then immediately returned to the PMT and monitoring was restarted (Fig. 7C). For 
melatonin removal and forskolin treatment, PT slices on culture membranes were transferred to other 
dishes containing fresh medium with vehicle or forskolin. The dishes were then immediately returned to 
the PMT and monitoring was restarted (Fig. 8). In Fig. 9C, serotonin was applied at approximately 12 h 
after the start of the culture to neonatal PT slices from CD-1 mice. 
 
Quantitative RT-PCR (qPCR) 
For qPCR experiments of the pituitary composed of the anterior and posterior lobes, TSHβLuc mice were 
decapitated at ZT2 to 6 under L12 : D12 conditions to collect the part of the tissue embedded in the sella 
turcica (pituitary fossa) from 12-week-old male TSHβLuc mice and temporarily stocked at −80 °C for 
further use. The total RNA was prepared from each pituitary, using RNeasy micro kit (Qiagen, Valencia, 
CA, USA). The cDNAs were synthesized from 0.25 µg of the total RNA using Superscript III 
transcriptase (Invitrogen). qPCR was performed using SYBR Green PCR Master Mix (Applied 
Biosystems, Foster City, CA, USA). 
For qPCR experiments of the cultured PT samples, the cultured PT samples were collected 48 h after the 
start of the culture. The total RNA was prepared from each cultured PT, using NucleoSpin RNA XS kit 
(Takara, Otsu, Japan). The cDNAs were synthesized from 0.05 µg of the total RNA of the cultured PT 
using Superscript Vilo transcriptase (Invitrogen). 
qPCR was performed using Quantitect SYBR Green PCR mastermix (Qiagen). qPCR was performed 
using the ABI PRISM 7900 (Applied Biosystems) at the following conditions: Samples contained 1 × 
SYBR Green PCR Master Mix or QuantiTect SYBR Green PCR Master Mix, 0.8 µM primers and 1/50 
synthesized cDNA in a 10-µL volume. The PCR conditions were as follows: 10 min at 95 °C, then 45 
cycles of 15 s at 94 °C, 1 min at 59 °C. The absolute cDNA abundance was calculated using a standard 
curve obtained from murine genomic DNAs. I used TATA box-binding protein (Tbp) or actin, beta (Actb) 
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as the internal controls. Primer information is as follows: 
TSHβ mRNA (exon 4): 
Forward primer: 5′-GTGGGCAAGCAGCATCCTTTTG-3′ 
Reverse primer: 5′-GCACACTCTCTCCTATCCACGTAC-3′ 
Cga mRNA: 
Forward primer: 5′-TGCTGAGCCGAGCCATTCAATG-3′ 
Reverse primer: 5′-GAAGTCTGGTAGGGAGGAGGTGG-3′ 
Luc mRNA: 
Forward primer: 5′-TCCTCAACGTGCAAAAGAAGCTACC-3′ 
Reverse primer: 5′-GTCGGTCTTGCTATCCATGATGATGATC-3′ 
Actb mRNA: 
Forward primer: 5′-TTGTCCCCCCAACTTGATGT-3′ 
Reverse primer: 5′-CCTGGCTGCCTCAACACCT-3′ 
TSHβ mRNA: 
Forward primer: 5′-CTGCATACACGAGGCTGTCAG-3′ 
Reverse primer: 5′-CCCCAGATAGAAAGACTGCGG-3′ 
Eya3 mRNA: 
Forward primer: 5′-TTCACAGCTCCAAGTAGAATCTGACT-3′ 
Reverse primer: 5′-TATGGAAGCGCCATGAGCTT-3′ 
Tbp mRNA: 
Forward primer: 5′-CCCCCTCTGCACTGAAATCA-3′ 
Reverse primer: 5′-GTAGCAGCACAGAGCAAGCAA-3′ 
 
PMT bioluminescence measurements 
The time-course bioluminescence results were obtained as reported previously (Isojima et al. 2009). PMT 
measurements with a high-sensitivity bioluminescence detection system (LM-2400; Hamamatsu 
Photonics, Hamamatsu, Japan) were started immediately after the start of PT slice culture at the time of 
lights-off (ZT12 for neonatal PT slices, ZT8 or 16 for adult short- or long-day slices). For the data 
analysis in Fig. 3B and D, raw photon counts were plotted. For the data analysis in Figs 3C, E, 5-8, 9B, 
10B, 11A and 12, photon counts of the PT slice from heterozygous TSHβLuc mice were calculated by 
subtracting background photon counts of PT slice from wild-type mice. For experiments in which 
reagents were added at the start of the culture, the resultant values were further normalized by photon 
counts at ZT4.75, which is 12.75 h after the start of the culture in adult long-day slices (Fig. 3C), or at 
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ZT23, which is 11 h after the start of the culture in neonatal PT slices (Fig. 3E, 6D, E, 7D, and 10B), 
which were the median time for the lowest bioluminescence values from all vehicle-treated samples in 
adult and neonatal slices, respectively (Fig. 13). For experiments in which reagents were added after the 
start of the culture, the resultant values were normalized by photon counts at ZT13.45, ZT19.75, ZT3.75, 
or ZT11.75 which are just before reagent treatments in neonatal PT slices (Fig. 5, 6B, C, 6F, 7A-C, 8, 9B, 
11A, and 12). In Fig. 6A, the resultant values were further normalized by photon counts at ZT22.75, 
which is 10.75 h after the start of the culture in vehicle-treated samples, or at ZT11, which is 23 h after 
the start of the culture in forskolin-treated samples, which were the lowest bioluminescence values from 
each sample. 
 
Bioluminescence imaging 
Samples were prepared as described above. Sealed 35-mm culture dishes were placed on the stage of a 
macrozoom microscope (MVX10; Olympus, Tokyo, Japan) in a dark hood. The culture dishes were kept 
at approximately 37 °C in a heated chamber (Tokai Hit, Shizuoka, Japan) on the microscope stage. 
Bioluminescence was imaged using a 1.6 × Plan Apochromat objective (NA 0.24; Olympus) with 6.3 × 
zoom and transmitted to an electron-multiplying charge-coupled device (EM-CCD) camera cooled to 
−80 °C (ImagEM; Hamamatsu Photonics). The dimension of an image is 512 × 512 pixels, and each pixel 
corresponds to the size of 1.587 × 1.587 µm. Exposure time was 29 min with EM gain of 200 × for 
snapshot images, and exposure time was 14 min with EM gain of 300 × for time-lapse images. Images 
were transferred at 690 KHz to minimize readout noise, and analyzed using MetaMorph software 
(Molecular device, Sunnyvale, CA, USA). Single-cell tracking was performed as previously described 
(Ukai et al. 2007). 
 
Fluoxetin and paroxetin administration 
Male 3-week-old CBA/N mice were singly housed under L12 : D12 conditions (400 lux) with food and 
water available ad libitum. 5-week-old mice were acclimated to 0.2% saccharin water for 1 week. 
Fluoxetin and paroxetin administration was carried out as previously described (Kobayashi et al. 2008; 
Kobayashi et al. 2010; Kobayashi et al. 2011). Fluoxetine hydrochloride (Wako Pure Chemical Industries, 
Ltd., Osaka, Japan) and paroxetine hydrochloride (Toronto Research Chemicals Inc., Toronto, Canada) 
were orally applied to 6-week-old mice for 2 weeks at a dose of 10 or 22 mg/kg/ day and 10 or 30 mg/kg/ 
day, respectively. The fluoxetine solutions and the paroxetin solutions were prepared everyday, and 
concentrations of fluoxetine and paroxetin were determined for individual mice based on the water 
consumption during preceding 24 h and the body weight measured every other day. 0.2% saccharin was 
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included in the fluoxetine solution and the paroxetin solution. Control mice were given water with or 
without saccharin, and all data were pooled. After 2 weeks of fluoxetine and paroxetine administration, 
mouse brain samples were collected to perform RI in situ hybridization. 
 
Mass spectrometry 
The YALSQDVCTYR peptide, which was the unique sequence for TSHβ, was synthesized on a peptide 
synthesizer (Syro Wave; Biotage, Uppsala, Sweden) using Fmoc solidphase chemistry. The peptide was 
dimethyl-labeled with formaldehyde (CD2O) and desalted by C18 StageTips according to previously 
described method (Boersema et al. 2009). The dimethyl labeling of the peptide was checked by liquid 
chromatography coupled with tandem mass spectrometry (LC-MS/ MS) with an LTQ orbitrap velos mass 
spectrometer (Thermo scientific, Waltham, MA, USA) coupled to a nano-Advance UHPLC system 
(Bruker Daltonics, Leipzig, Germany). 
The culture medium of the PT slices was collected and temporarily stocked at −80 °C for further use. 
Proteolytic digestion was performed using a phase-transfer surfactant protocol (Masuda et al. 2008; 
Narumi et al. 2012). The resultant digest was dimethyl-labeled with formaldehyde (CH2O). 
For quantification by mass spectrometry, a triple quadrupole mass spectrometer (TSQ Vantage EMR; 
Thermo scientific) was used to design a selected reaction monitoring (SRM) method. LC-SRM/MS was 
performed by a TSQ Vantage EMR mass spectrometer equipped with a nanoLC interface (AMR), a 
nano-Advance UHPLC system (Bruker Daltonics) and an HTC-PAL autosampler (CTC Analytics, 
Basingstoke, UK). The parameters of the mass spectrometer were set as follows: 0.002 m/z scan width, 
40 msec scan time, 0.7 fwhm Q1 and Q3 resolution and 1.8 mTorr gas pressure. 
For data analysis of the peak area in the chromatogram of each SRM transition, the peak area was 
extracted by using Pinpoint software (Thermo scientific). To confirm whether the peaks of SRM 
chromatogram were derived from the endogenous YALSQDVCTYR peptide, we checked that ratios 
among the peak areas of 6 SRM transitions were comparable with those of the standard 
YALSQDVCTYR peptide. Three of six SRM transitions, which had a lower variability in the ratio 
between the 18 runs of LC-SRM/MS analysis, were used for the quantification of the endogenous 
YALSQDVCTYR peptide. Chromatograms of SRM transition are shown in Fig. 14. Interassay 
coefficient of variation was 7.9%. The lower limit of sensitivity was 13.27 attomole. 
 
Statistical analyses 
All data are shown as means ± SEM. Comparison of two groups was made using two-sample t-test. A 
value of P < 0.05 was considered as statistically significant. The analyses were performed by Microsoft 
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Excel (Microsoft, Redmond, WA, USA) or R software (see The Foundation for Statistical Computing, 
http://www.R-project.org). 
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Figure 1. Generation of TSHβLuc mice. (A) Targeting schema. Exons 1–5 are indicated by solid boxes. 
TSHβ ORF is indicated by filled boxes. Luc ORF sequence was inserted in frame to the first ATG of exon 
4 of the TSHβ gene. The hybridization probes used for Southern blot analysis (5′, 3′ and Neo probes) and 
PCR primers for routine genotyping (P1-P3) are indicated by bold black lines and black arrowheads, 
respectively. (B) Southern blot analysis of the 5′ region (left) and genotyping PCR (right). Wild-type 
allele, heterozygous and homozygous mutant alleles are indicated as WT, +/L and L/L, respectively. One 
extra band was appeared in the +/L lane in genotyping PCR (right). (C) Expression levels of TSHβ, Cga 
and Luc in the pituitary of TSHβLuc mice by using quantitative RT-PCR (qPCR). The statistical 
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differences between wild-type and heterozygous or homozygous TSHβLuc mice were calculated. *P < 
0.05; **P < 0.01 (two-sample t-test, n = 6–8, average ± SEM). (D) Growth curves in male TSHβLuc mice. 
The statistical differences between wild-type and heterozygous or homozygous TSHβLuc mice were 
calculated. **P < 0.01 (two-sample t-test, n = 6–8, average ± SEM). 
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Figure 2. Photoperiodic gene responses in TSHβLuc mice. (A) Experimental schema. 3-week-old mice 
were transferred to short-day (SD; light/dark = 8:16 hour) or long-day (LD; light/dark = 16:8 h) 
conditions and maintained for 3 weeks. Brain samples were collected 4 h before lights-off (ZT4 of SD 
and ZT12 of LD). (B) Expressions of TSHβ, Luc and Cga under SD and LD conditions in wild-type (WT) 
and heterozygous TSHβLuc mice (+/L) measured by radioisotope (RI) in situ hybridization. The signal 
intensities were quantified and normalized by the values in SD samples except Luc measurement in WT 
mice. Scale bar: 300 µm. ND, not detected. *P < 0.05 (two-sample t-test, n = 3–5, average ± SEM). (C) 
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Bioluminescence imaging of the PT. Adult PT slices were prepared from LD conditioned mice and 
neonatal PT slices were prepared from L12 : D12 conditioned mice. Bright-field and corresponding 
bioluminescence CCD images captured from the representative PT slices are shown. Scale bar: 100 µm 
(see also Fig. 4). 
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Figure 3. Real-time monitoring of the TSHβ expression by bioluminescence. (A) Experimental schema. 
Neonatal PTs were collected at postnatal 6–8 (P6–8) under L12 : D12 conditions, and 5- to 6-week-old 
mice were collected after being maintained in short-day (SD) or long-day (LD) conditions for 2–3 weeks. 
(B and D) Real-time bioluminescence recording in adult or neonatal PT slices of indicated genotypes. 
White and black bars on the graphs indicate the subjective day and night on the following days after 
sampling, respectively [n = 2, wild-type (WT) mice or n = 6, heterozygous TSHβLuc mice (+/L) in B; n = 5, 
WT and n = 17, +/L in D, average ± SEM]. (C and E) Real-time monitoring of the luciferase (luc) 
reporter activities in adult or neonatal PT slices after the addition of vehicle (Veh) or melatonin (Mel). 
The PT slices were prepared from animals kept under LD (adult, C) or L12 : D12 (neonate, E) conditions. 
Vehicle or melatonin was applied at the start of the culture. Data were normalized by the values of photon 
count at ZT4.75 (adult, C) or ZT23 (neonate, E, see Experimental procedures). Normalized luc reporter 
activities of PT slices from +/L mice are shown (n = 4 in C and n = 3–4 in E, average ± SEM). (F) 
Confirmation of expression level changes in TSHβ, Eya3 and Cga in the cultured PT by qPCR analysis. 
Neonatal PT slices were treated with vehicle or 10 nM melatonin 48 h with PMT monitoring. Expression 
levels of TSHβ, Eya3 and Cga were normalized by the value of Six5 or Kcnq5, which were specifically 
expressed in the PT. *P < 0.05; **P < 0.01 (two-sample t-test, n = 9, average ± SEM). Correlation 
between TSHβ mRNA levels and bioluminescence counts (right). White circles (Veh) and gray circles 
(Mel) indicate data points. The line is regression: r2 = 0.71. (G) Quantification of secreted amounts of 
TSHβ into the culture medium of the PT slices in 3F by mass spectrometry analysis. **P < 0.01 
(two-sample t-test, n = 9, average ± SEM). Correlation between secreted TSHβ amounts (middle) and 
TSHβ mRNA levels or bioluminescence counts (right). White circles (Veh) and gray circles (Mel) 
indicate data points. The line is regression: r2 = 0.81 (middle), r2 = 0.66 (right). 
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Figure 4. Time-lapse bioluminescence imaging of the PT. (A) Time-lapse images of neonatal PT slice 
from heterozygous TSHβLuc mice kept under L12:D12 conditions. Scale bar: 100 µm. (B) Representative 
bioluminescence patterns in individual neonatal PT cells in Fig. 4A. Scale bar: 100 µm. 
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Figure 5. Real-time monitoring of the luciferase reporter activities in neonatal PT slices with glutamine or 
glutamic acid treatment. 1 mM glutamine (Gln) or 1 mM glutamic acid (Glu) containing medium and 
control medium that does not contain glutamine and glutamic acid (Veh) was replaced 2 h after glutamine 
and glutamic acid starvation from the start of the culture. Lower panel shows data that are 12 h after the 
start of the culture in upper panel. Normalized luciferase reporter activities of neonatal PT slices from 
heterozygous TSHβLuc mice kept under L12:D12 conditions are shown. (n = 5, average ± SEM). White 
and black bars on the graphs indicate the subjective day and night on the following days after sampling, 
respectively. ZT12 is the start of subjective night and the culture was started at the time point. 
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Figure 6. Effects of drugs targeting the cAMP signal on bioluminescence activity. Real-time monitoring 
of the luciferase (luc) reporter activities in the neonatal PT slices with vehicle (Veh) or reagents. (A-C) 
An adenylate cyclase activator (Fsk, forskolin) treatment. (A) Vehicle or 1 µM of forskolin was applied at 
the start of the culture. Data were normalized by the lowest values of photon count in each condition. (B) 
Vehicle or 1 µM of forskolin was applied at 8 h after the start of the culture. Data were normalized by the 
values of photon count just before treatment. (C) Vehicle or 1 µM of forskolin was applied at 8+24 h after 
the start of the culture. Data were normalized as in (B). Normalized luc reporter activities of neonatal PT 
slices from heterozygous TSHβLuc mice housed under L12:D12 conditions are shown (n = 1 in A, n = 3-5 
in B, and n = 3-4 in C, average ± SEM). (D) A protein kinase A (PKA) agonist (PKA ag, 6-Bnz-cAMP) 
or an exchange protein directly activated by cAMP (Epac) agonist (Epac ag, 8-CPT-2′-O-Me-cAMP) 
treatment. Vehicle, PKA ag or Epac ag was applied at the start of the culture. Vehicle (dilution 1 : 200 or 
1 : 40), 100 or 500 µM of PKA ag (dilution 1:200), 2.5 mM of PKA ag (dilution 1:40), 100 µM Epac ag 
(dilution 1:200), or 500 µM of Epac ag (dilution 1:40) was applied to medium. Data were normalized by 
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the values of photon count at ZT23. Normalized luc reporter activities of neonatal PT slices from 
heterozygous TSHβLuc mice housed under L12:D12 conditions are shown (n = 1-3, average ± SEM). (E) 
An adenylate cyclate inhibitor (MDL, MDL-12,330A) treatment. Vehicle, 1 or 10 µM of MDL was 
applied at the start of the culture. Data were normalized by the values of photon count at ZT23. 
Normalized luc reporter activities of neonatal PT slices from heterozygous TSHβLuc mice housed under 
L12:D12 conditions are shown (n = 3, average ± SEM). (F) Melatonin (Mel) and pertussis toxin (PTX) 
treatment. Vehicle, 10 µM of melatonin with/without 1 µg / mL of PTX was applied at 8+24 h after the 
start of the culture. Data were normalized by the values of photon count just before treatment. Normalized 
luc reporter activities of neonatal PT slices from heterozygous TSHβLuc mice housed under L12:D12 
conditions are shown (n = 1-3, average ± SEM). White and black bars on the graphs indicate the 
subjective day and night on the following days after sampling, respectively. ZT12 is the start of 
subjective night and the culture was started at the time point. 
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Figure 7. Effects of drugs targeting intracellular signaling pathways on bioluminescence activity. 
Real-time monitoring of the luciferase (luc) reporter activities in the neonatal PT slices with vehicle 
(Veh) or reagents. (A) A protein kinase C activator (TPA, 12-O-tetradecanoyl phorbol 13-acetate) 
treatment. Vehicle, 0.2, 2, or 20 µM of TPA was applied at 8+48 h after the start of the culture. (B) A 
phospholipase C activator (m-3M3FBS) treatment. Vehicle, 2.5 or 25 µM of m-3M3FBS was applied at 
8+48 h after the start of the culture. (C) A calcium ionophore (ionomycin) treatment. Vehicle or 1 µM of 
ionomycin was applied for 30 min at 8+24 h after the start of the culture. (D) KCl treatment. Vehicle, 10 
or 60 mM of KCl was applied at the start of the culture. Data were normalized by the values of photon 
count just before treatment (A-C) or at ZT23. Normalized luc reporter activities of neonatal PT slices 
from heterozygous TSHβLuc mice housed under L12:D12 conditions are shown (n = 2-4 in A, n = 3-5 in B, 
n = 1 in C, and n = 3 in D, average ± SEM). White and black bars on the graphs indicate the subjective 
day and night on the following days after sampling, respectively. ZT12 is the start of subjective night and 
the culture was started at the time point. The measurement was started at ZT12 (A, C and D) or ZT20 (B). 
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Figure 8. Time-dependency of bioluminescence activity to melatonin removal with/without forskolin 
treatment. Real-time monitoring of the luciferase (luc) reporter activities in the neonatal PT slices with 
treatments at different three timings. (A) Melatonin removal. 10 pM of melatonin (Mel) was applied at 
the start of the culture. Culture medium was replaced with the fresh culture medium with vehicle (Veh) or 
10 pM of melatonin at ZT20, 4, or 12, which are 8, 16, or 24 h after the start of the culture, respectively. 
(B) Melatonin removal with vehicle or forskolin (Fsk) treatment.10 pM of melatonin was applied at the 
start of the culture. Melatonin was removed and vehicle or 1 µM of forskolin was applied by medium 
changing at ZT20, 4, or 12, which are 8, 16, or 24 h after the start of the culture, respectively. Data were 
normalized by the values of photon count just before treatment. Normalized luc reporter activities of 
neonatal PT slices from heterozygous TSHβLuc mice housed under L12:D12 conditions are shown (n = 3 
in A and n = 3 in B, average ± SEM). White and black bars on the graphs indicate the subjective day and 
night on the following days after sampling, respectively. ZT12 is the start of subjective night and the 
culture was started at the time point.  
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Figure 9. Serotonin effects on TSHβ expression. (A) Expression patterns of serotonin receptor subtypes. 
Expression patterns of serotonin receptor subtypes in CBA/N mice were analyzed by radioisotope (RI) in 
situ hybridization. Red boxes indicate the serotonin receptor subtypes expressed in the PT. Scale bar: 300 
µm. (B) Real-time monitoring of the luciferase (luc) reporter activities in the neonatal PT slices with 
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vehicle (Veh) or serotonin treatment. Vehicle, 5, 10, or 30 µM of serotonin was applied at 8+24 h after 
the start of the culture. Data were normalized by the values of photon count just before treatment. 
Normalized luc reporter activities of neonatal PT slices from heterozygous TSHβLuc mice housed under 
L12:D12 conditions are shown (n = 3-4, average ± SEM). White and black bars on the graphs indicate the 
subjective day and night on the following days after sampling, respectively. ZT12 is the start of 
subjective night and the culture was started at the time point. (C) Intrinsic fluorescence of serotonin was 
measured by PMT. Raw photon counts are shown (n = 2-3, average ± SEM). Vehicle or serotonin was 
applied at approximately 12 h after the start of the culture to the neonatal PT slices from CD-1 mice that 
do not carry the luciferase reporter. (D) Selective serotonin reuptake inhibitors (SSRIs) administration. 
Vehicle, 10 or 22 mg/kg/day of fluoxetine (F10 or F22), or 10 or 30 mg/kg/day of paroxetine (P10 or 
P30) was chronically administrated for 2 weeks to short-day conditioned CBA/N mice. Expression of 
TSHβ was measured by radioisotope (RI) in situ hybridization. There was no significant difference 
between vehicle- and SSRIs-administrated groups (two-sample t-test, n = 3, average ± SEM). 
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Figure 10. Screening of candidate G-protein coupled receptors (GPCRs). (A) Expression patterns of 
candidate GPCRs. Expressions of melatonin receptror (Mtnr1a), TSH receptor (Tshr), S1pr3, Cysltr1, and 
Fzd5 in CBA/N mice were measured by radioisotope (RI) in situ hybridization. Red boxes indicate the 
candidate GPCRs expressed in the PT. Scale bar: 300 µm. (B) Real-time monitoring of the luciferase 
(luc) reporter activities in the neonatal PT slices with vehicle (Veh) or thyroid stimulating hormone 
(TSH) treatment. Vehicle, 1 or 10 mIU/mL of TSH was applied at the start of the culture. Data were 
normalized by the values of photon count at ZT23. Normalized luc reporter activities of neonatal PT 
slices from heterozygous TSHβLuc mice housed under L12:D12 conditions are shown (n = 2-3, average ± 
SEM). White and black bars on the graphs indicate the subjective day and night on the following days 
after sampling, respectively. ZT12 is the start of subjective night and the culture was started at the time 
point. 
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Figure 11. Prokineticin 2 (PK2) effects on bioluminescence activity. (A) Real-time monitoring of the 
luciferase (luc) reporter activities in the neonatal PT slices with vehicle (Veh) or recombinant PK2 
treatment. Vehicle or 20 nM of recombinant PK2 was applied at 8+48 h after the start of the culture. Data 
were normalized by the values of photon count just before treatment. Normalized luc reporter activities of 
neonatal PT slices from heterozygous TSHβLuc mice housed under L12:D12 conditions are shown (n = 5-6, 
average ± SEM). White and black bars on the graphs indicate the subjective day and night on the 
following days after sampling, respectively. ZT12 is the start of subjective night and the culture was 
started at the time point. The measurement was started at ZT17. (B) Expression patterns of prokineticin 
receptor 2 (Pkr2). Expression pattern of Pkr2 in CBA/N mice was analyzed by radioisotope (RI) in situ 
hybridization. Pkr2 was not detected in the PT (left). Signal was detected in the SCN, which is a positive 
control tissue (right) (Cheng et al. 2002). Scale bar: 300 µm. 
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Figure 12. Effects of glutamic acid receptor agonists on bioluminescence activity. Real-time monitoring 
of the luciferase (luc) reporter activities in the neonatal PT slices with vehicle (Veh), kainic acid (KA), 
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), or N-methyl-D-aspartic acid 
(NMDA) treatment. 50 µM of KA, 50 µM of AMPA, or 50 µM of NMDA containing medium or control 
medium that does not contain glutamine and glutamic acid with or without vehicle of KA [Veh (KA) or 
Veh] was replaced 2 h after glutamine and glutamic acid starvation at the start of the culture. Lower panel 
shows data that are 12 h after the start of the culture in upper panel. Data were normalized by the values 
of photon count just before treatment. Normalized luciferase reporter activities of neonatal PT slices from 
heterozygous TSHβLuc mice housed under L12:D12 conditions are shown. (n = 3-4, average ± SEM). 
White and black bars on the graphs indicate the subjective day and night on the following days after 
sampling, respectively. ZT12 is the start of subjective night and the culture was started at the time point. 
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Figure 13. Histograms of the bottom time of bioluminescence of adult long-day PT samples (n = 19, 
upper) and neonatal PT samples (n = 157, bottom) that were treated with vehicle. The median time 
(ZT4.75 in adult long-day, ZT23 in neonate) was indicated as dash lines. ZT16 in upper panel and ZT12 
in lower panel mean the start time of the culture. 
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Figure 14. The chromatograms of each selected reaction monitoring (SRM) transition. (A) Experimental 
schema. The culture medium of the PT slices was collected and digested. The resultant digest was 
dimethyl labelled with formaldehyde (CH2O). Synthetic peptide for reference was dimethyl labelled with 
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formaldehyde (CD2O). Each peptide was desalted by C18 StageTips and quantified by mass spectrometry. 
See Experimental procedures. (B) Amino acid sequence of TSHβ. Box indicates reference peptide 
sequence. (C) SRM transition parameters. CE means collision energy. †; The SRM transitions were used 
for quantification. (D) Relative intensity of each SRM transitions of reference peptides. (E) 
Chromatograms of endogenous peptides from the medium (each upper column) and synthetic peptides 
(each bottom column) are shown. The x-axis scale is 0.05 min per division. 
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